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INTRODUCTION 
Behaviors refer to the actions made by organisms, in conjunction with their 
environment, which includes the other systems of organisms around as well as the 
physical environment. It is the response of the organism to various stimuli or inputs, 
whether internal or external, conscious or subconscious, overt or covert and voluntary 
or involuntary (Bazzett, 2008). 
Behavior of human beings develops in response to interaction between inherited 
limitations and envirormiental factors. Though a wide range of biological conditions 
such as defective genes, disease, endocrine imbalance, malnutrition, injuries, and 
other such condition that interfere with normal development and functioning are 
potential cause of abnormal behavior, however environmental factors also influence 
numerous aspects of our behavioxir. 
The heredity not only provides potentialities for development and behavior typical of 
the species but also is an important source of individual differences. Since our 
behavior is inevitably influenced by our biological inheritance it should hardly be 
surprising that certain vulnerabilities have their roots in the genetic material of 
chromosomes. The chromosomal anomalies interfere directly with the normal 
development of the brain, others are more subtle defects but they can still render a 
person susceptible to the most severe of the mental disorders (Ronald and Mark 
1999). These subtle influences are transmitted in the genetic code itself, manifesting 
themselves as metabolic or biochemical irregularities. Psychogenetic or behavioral 
genetics is a newly rising and challenging field which deals with all types of normal 
and abnormal behavioral traits in all animals as well as human beings. 
The great majority of people show normal behavior with slight deviation in it in 
certain specific conditions. However a small group of individual almost in every 
population deviates fi-om the normal in an unfavorable or pathological direction, 
included in this small fi-action are the individuals marked by limited intelligence, 
emotional instabilities, personality disorganization and character defects. These 
abnormal deviants usually classified by the psychiatrists into four main categories i.e., 
antisocial personality, mentally defective people, sufferers of psychosis and the 
sufferers of psychoneurosis. (DSM-IV-TR, 2000) 
Psychoneurotic symptoms are anxiety, feeling of inner tension, restlessness, idea of 
inadequacy, depressed spirits to concentrate or make decisions, memory disturbance, 
heightened irritability, irrational fear, obsessions, compulsions and inability to enjoy 
social relations. (DSM-IV-TR, 2000) 
Though the psychoneurotic disorders i.e., anxiety disorders, (OCD, phobia etc.) are 
most widespread amongst the mental disorders, they produce only mild to moderate 
ilhiess and therefore these are mostly studied by psychologists not by psychiatrists 
and psycho geneticists. The other reason perhaps of fewer researches on these is that 
there is no concrete genetic evidence reported for these disorders and also due to the 
fact that most of these are not following the classical Mendelian inheritance patterns. 
Therefore these are categorized imder the complex genetic disorders, which may 
involve combined effect of mutations in multiple alleles/genes and number of 
environmental influences that generally control their penetrance and expressivity in a 
given population. (Kendler et al. 1995) 
The anxiety disorders are the most common type of psychoneurotic disorders in 
human population (Marks 1988). The study of anxiety disorders possess a challenge 
because anxiety can be manifested through a variety of phenomena showing 
subjective sense of increase; a set of behavior such as avoidance and restlessness on a 
physiological response originating in the nervous system, such as increased heart 
rate, perspiration and muscle tension. These phenomena are not in themselves 
abnormal but are considered "disorders", when they lead to marked distress 
impairment in functions (DSM-IV-TR, 2000). Even in the realm of anxiety disorders, 
the subjective experience of anxiety differs markedly. In panic disorder (PD) and 
generalized anxiety disorder (GAD), the anxiety is unfocused, phobias and post 
travimatic stress disorder (PTSD) involve a fear around by specific identifiable objects 
or situations and in obsessive compulsive disorder (OCD), anxiety occurs when the 
patient resists a thought or behavior. (DSM-IV-TR, 2000) 
CLASSIFICATION OF ANXIETY DISORDERS ACCORDING TO DSM-IV 
In 1952 the American psychiatric Association Committee on nomenclature and 
statistics, published the first edition of DSM-I i.e.. Diagnostic and statistical manual 
of mental Disorders, DSM-II published in 1968 and four editions are published since 
then. 
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The fourth edition of diagnostic and statistical manual of mental disorders (DSM-IV) 
published in 1994 and its revision in 2000 (DSM-IV-TR), is the latest most up-to-date 
classification of mental disorders. The fourth edition correlates with the 10* revision 
of world health organization (WHO's), international classification of diseases and 
related health problems (ICD-10) developed in 1992. 
BASIC FEATURE of DSM-IV: 
DSM-FV attempts to describe what the manifestations of mental disorders are. 
Specified diagnostic criteria are provided for each mental disorder. Those criteria 
include a list of features that must be present for diagnosis to be made, thus increasing 
the validity and reliability of the diagnostic process among clinicians. 
The DSM-IV revised fourth edition of diagnostic and statistical manual of mental 
disorder (DSM-FV-TR) revised anxiety disorders into the following groups. 
Panic Disorder: typified by recurrent, unexpected attacks of multiple somatic and 
cognitive fear symptoms, this can occur with or without agoraphobia. 
Agoraphobia: fear of experiencing panic in situations with no opportunity for 
escape. 
Post-Traumatic Stress Disorder: (PTSD) typified by intrusive, distressing 
memories of a traumatic event, avoidance of activities and other cues related to the 
trauma and persistent hyperarousal. 
Generalized Anxiety Disorder: (GAD) a chronic pattern of excessive, 
uncontrollable worry, muscle tension, and related physical features. 
Social Anxiety Disorder (SAD): characterized by avoidance of social situations due 
to fear of negative evaluation. 
Obsessive Compulsive Disorder (OCD): characterized by intrusive obsessions and 
compulsive behaviors, and 
Specific Phobias: excessive fear and avoidance of a circumscribed class of objects, 
contexts, etc. 
PHOBIA 
Word phobia originated from "phobos" (Greek) means fear or terror. A phobia is an 
irrational fear of a specific object, activity or situation that resuhs in a compelling 
desire to avoid the dreaded object, activity and situation (American Psychiatric 
Association, DSM, 1980). A phobia is brought on by a specific stimulus or situation, 
for example blood, closed spaces, heights, crowds or the dentist, animals etc. 
Presentation with the fear inducing stimulus cause a severe anxiety response with 
very apparent and specific physical manifestations, such as rapid heartbeat, shortness 
of breath trembling and sweating. Most individuals suffering from phobia are able to 
recognize that their fear is fimdamentally irrational. Yet nonetheless go through 
grunts length to avoid contact with the given stimulus (Marks 1988). 
When Are Fears Considered Phobias. 
Fear is an adaptive human response to danger, it severs a protective purpose, by 
activating a "Fight or Flight" response of the sympathetic nervous system. When 
faced with danger our excess adrenaline, prepares us to fight or to flee the physical 
threat. The fight or flight response includes an increase in heart rate and blood flow to 
our large muscles, better enabling us to react to the emergency. Blood sugar also 
increases, providing us with more energy, with our bodies and minds alert and ready 
for action, we are able to respond quickly and protect ourselves (Bracha 2004). 
Although it is normal and even helpfial to experience fear in dangerous situations, 
with phobias the danger is greatly exaggerated or imagined (Marks 1988) Many of 
the phobic objects or things which would cause discomfort under certain 
circumstances in a number of people can cause much more intense anxiety in the 
phobic subjects (Marks 1988, Page 1994) that is the fears become a reason for 
concern when persistent and interferes with the daily functioning of the sufferer, 
when the fear reaches this end of intensity, it is often identified as a phobia. 
Physical Symptoms of Phobia according to DSM-IV 
The individual may experience a whole range of physiological responses in the 
presence phobic stimuli, including. 
• Increased heart rate. 
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• Palpitations 
• Perspirations 
• Nausea 
• Diarrhoea 
• Dizziness 
• Sensations of chocking 
• Suffocation etc. 
Though the experience of phobia is relatively common and their physical 
characteristics are generally well understood, there is no real consensus on the 
neurobiological basis of phobia. Instead there are currently several different models 
and theories that work to try to understand how and why phobias occur in the human 
brain. Most hypothesis regarding phobias take different approaches from biological to 
psychoanalytic to evolutionary. (Marks 1988, Page 1994, Bracha 2004, Hamilton 
1995) 
Some scientists such as Martin Seligman believe that people are inherently 
"prepared" to fear certain objects. Other scientists, such as Le Doux (1998) believe 
that preparedness and the ease of conditioning are the results of certain persisting 
neurobiological conditions that exist evolutionary; these conditions are turned on with 
relative case. 
The most widely accepted classification subdivides phobias into three main types 
(American Psychiatric Association, DSM-1980) 
I. Agoraphobia. 
II. Specific/simple Phobia. 
III. Social Phobia. 
SPECIFIC PHOBIA/ SIMPLE PHOBIA 
Specific phobia is a type of disorder in which the affected individual displays a 
marked and enduring fear of specific situations or objects. Individuals with specific 
phobias experience extreme fear as soon as they encounter a defined situation or 
object; a phobic stimulus for example is that if an individual with a specific phobia of 
dogs will become anxious when coerced to confront a dog. The specific phobia 
triggers a lot of distress or significantly impairs an affected individual. 
Mental health professionals use the diagnostic and statistical Manual (DSM) to 
diagnose mental disorders. The 2000 edition of this manual (the fourth edition Test 
revision, also called the DSM-IV-TR) classifies specific phobia as a type of anxiety 
disorder. Formerly specific phobias were known as simple phobia. 
Specific phobias has a unique position among the anxiety disorders in that individuals 
with this disorder do not experience pervasive anxiety, nor do they seek treatment as 
readily as individuals with other anxiety disorders, unlike individuals with other 
anxiety disorders, the fear of individuals with specific phobia is limited to defined 
situations or objects. Individuals with specific phobias experience impairment or a 
significant amount of anguish. They may lead restricted life styles depending upon 
the phobia type. 
Adults and adolescents with specific phobia recognize that their fear is unreasonable; 
children on the other hand may not recognize that their fear of the phobic stimulus is 
unreasonable or extreme. 
CAUSES 
The development of a specific phobia may be determined by a variety of factors. 
Behavioural, cognitive, and social theories of learning and conditioning, 
psychodynamic models such as the psychoanalytic theory of Freud, physiological 
studies of the brain, family background and the genetic predisposition, variations in 
socio-cultural themes, and theories on trauma can influence the development of 
specific phobia disorder. Some theorists propose that biological researchers have 
ignored specific phobias because pharmacological treatment is not the treatment of 
choice for this disorder. 
TRAUMATIC CAUSES :-
Psychologists consider that a determinant of specific phobias includes trauma. For 
example, individuals who have been attacked by a dog may develop a specific phobia 
disorder and become conditioned to fear dogs. Individuals who observe others 
experiencing a trauma may become predisposed to developing specific phobia 
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disorder. For example, individuals who witness people falling from a building may 
develop a specific phobia disorder. 
PSYCHODYNAMIC CAUSES:-
Psychodynamic Theorists explain that phobias emerge because individuals have 
impulses that are unacceptable, and they repress these impulses. 
PHYSIOLOGICAL CAUSES:-
Unlike other types of anxiety disorders, there has been relatively little research on the 
role of biology in causing or maintaining specific phobias. Still. 
Some research has suggested that the high activation of brain pathways that 
correspond to the cognitive and emotional constituents of anxiety, biologically 
predispose individuals to specific phobias. 
In addition when a person is exposed to a feared object or situation, there are many 
biological changes that occur in the body, including changes in the brain activity, the 
release of certain hormones, (e.g., Cortisol, insulin, growth hormone) and increase in 
physical arousal symptoms (e.g., increased heart rate and blood pressure). (Petraglia 
et al. 2001, Federenko and Wadhwa, 2004) 
GENETIC AND FAMILY CAUSES 
Although specific phobia is frequently attributed to environmental issues such as 
modeling, learning by association and negative reinforcement. There is evidence that 
specific phobias run in families and that genetics may play a role and genetic 
predisposition can influence this disorder. An individual who has a family member 
with a specific phobia is at an increased risk for developing this disorder. 
PERSONAL VARIABLES: 
Studies suggest a relationship between age and specific phobia. Research indicates 
some connection between the age of individuals with specific phobias and insight into 
the exfreme quality of their fears. Insight increases with age. 
• 
SYMPTOMS 
DSM-IV-TR delineates seven diagnostic criteria for specific phobia. 
Significant and enduring fear of phobic stimulus: Patients with specific phobia 
display marked and enduring fear when they encounter a defined situation or object, 
the phobic stimulus. 
Anxiety response to pliobic stimulus: Patients with specific phobia display anxiety 
as soon as they confi-ont the phobic stimulus. When they confi-ont the phobic 
stimulus, a defined situation or object, they may experience a panic attack related to 
the specific situation. Children may cry cling, fi-eeze, or display tantrums when they 
express their anxiety in the face of the phobic stimulus. 
Recognition: Although adolescent and adults realize that their fear is unreasonable 
and disproportionate to the situation, children may not recognize that their fear is 
excessive. 
Avoidance: Individuals with specific Phobia avoid the phobic stimulus or endure it 
with deep distress and anxiety. 
Impairment and distress: Individuals with specific phobia display avoidance, 
distress, and anxious anticipation when they encounter the phobic stimulus. Their 
avoidance reactions interfere with their daily fimctioning, or they express significant 
distress about having a phobia. 
BLOOD/INJURY / INJECTION PHOBIA 
Blood injury injection phobia deals with a person's personal fear of blood, injury, 
injection/ needles and will cause them to strongly avoid most medical procedures. 
This phobia is most commonly noticed after a person faints or experiences a change 
in heart rate/extremely uncomfortable sensations around the sight of blood. Blood 
Phobia is being used in the literature as Blood, Injection and Injury phobia as these 
are the cues to elicit the phobic response. The diagnostic criteria for blood and 
injection phobia according to the DSM-IV (2000) are given 
Marked and persistent fear that is excessive or unreasonable cued by the presence or 
anticipated presence of a blood, injured person, or bleeding wound etc. 
Exposure to the phobic stimulus almost always provokes an immediate anxiety 
response, which may take the form of a situational bound or situational predisposed 
panic attack. 
The person recognizes that the fear is excessive or unreasonable. 
The phobic situation is avoided or else endured with intense anxiety or distress. 
The avoidance, anxious anticipation, or distress in the feared situation interferes 
significantly with the persons normal routine, occupational (academic) functioning, or 
social activities or relationship or there is marked distress about having the phobia, 
hi individuals under age 18 years, the duration is at least 6 months. 
The anxiety cannot be better explained by another anxiety disorder. 
Most cases are discovered in early childhood and require some method of treatment 
to overcome. People with blood injury injection phobia that have undergone treatment 
have shown an enormously positive success rate. 
Blood injury injection phobia can have grave implications and may even become life 
threatening. When it prevents essential medical procedures such as urgent surgery, 
blood transfusion, or insulin injections, treatment is almost always mandatory. Indeed 
such emergency is not an unconmion reason for referral (Marks, 1987). Such patients 
avoid close contact with sick people, refuse hospital appointments and would not 
view television programme or read newspaper reports about trauma or Disasters. 
Women sufferers may even avoid pregnancy as child birth is associated with blood 
and medical procedures (Marks, 1987). 
As blood injury phobia has received more empirical examination, it has become 
evident that while blood injury phobia shares the fundamental characteristics of the 
other specific phobias, it also differs in several important ways. A recent critical 
review of the literature outlined the factors on which blood injury phobia differs from 
other specific phobias including physiological response, treatment techniques, and the 
subjective emotion experienced (Stump, 2003). A recent study has found attentional 
bias predominantly among the subjects of BII Phobia and atentional avoidance were 
highly robust in BII phobics (Armstrong et al. 2013). 
These phobias are distinct from all other phobias in developing bradycardia and 
actual fainting when in contact with blood injury stimuli. Initially there may be a 
slight rise in heart rate and blood pressure. This usually lasts only a few seconds or 
the very most minutes, followed by marked vasovagal slowing of heart rate (Ost et al. 
1987). This exaggerated physiological response is commonly accompanied by a 
myriad of other symptoms such as nausea, sweating, pallor and syncope. 
However many individuals with blood injury do not experience the traditional fear 
response of heightened sympathetic nervous system activity demonstrated by increase 
in heart rate and blood pressure upon exposure to blood injury injection related 
stimuli. Instead, many individuals with blood injury injection phobia experience a 
diphasic response when they are confronted by the phobic object (Graham, Kabler, 
and Lvinsford; 1961). 
The diphasic response consists of an initial phase which resembles the traditional fear 
response, in which heart rate and blood pressure drop rapidly and in many cases, 
fainting occurs as the individual loses consciousness (e.g., Cannolly, Hallam and 
Marks, 1976 Cohn, Kron, and Brady, 1976, Curtis and Thyer 1983, Ost, Sterner and 
Lindahl, 1984). Blood injury phobia is virtually the only specific phobia, and the only 
anxiety disorder, in which fainting occurs, and it has been estimated that as many as 
70% of the individuals with blood phobia have fainted at least once upon exposure to 
blood injury injection stimuli (Ost, 1992). It is important to note that there are 
individuals who meet diagnostic criteria for blood injury injection phobia and do not 
have history of fainting. In Ost (1992), one of the most comprehensive studies of 
blood injury phobia, 30% of the blood phobics and 44% of injection phobics who met 
diagnostic criteria for blood injury phobia reported never having fainted in the phobic 
situation. Unfortunately there is a paucity of research that fully examines potential 
difference between blood injury phobics who faint compared with blood injury 
phobics without a fainting history. One more difference between blood injury phobia 
and other specific phobias is the potential role of the emotion of disgust in blood 
injury phobics (Cavusoglu and Dirik (2011). 
Although phobias are typically associated with fear, but an increasing amount of 
research has directed attention towards the emotion of disgust, particularly with 
regard to blood injury phobia and spider phobia as a number of studies have 
demonstrated heightened levels of disgust sensitivity in these populations (e.g., 
Sawchuk et al 2000, Sawchuk et al 2002, Sawchuk and Lee 1997). 
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In addition to the above differences blood injury injection phobia also differs from 
other specific phobias in the treatment techniques that are effective, largely due to the 
pattern of physiological response associated with blood injury injection phobia. A 
number of empirical studies conducted by Hellstrom and his colleagues have 
described and validated a treatment strategy known as applied tension (Hellstrom et al 
1996, Ost, Fellenius and Sterner, 1991). This technique involves tensing the different 
muscles of the body, which in turn prevents the drop in blood pressure that 
contributes to fainting. The rest of the treatment package is similar to that used with 
other specific phobia, in effect, clients are gradually exposed to various phobic 
stimuli and encouraged to practice the tension technique. 
So for as the literature on blood injection and injury phobia is concerned, there are not 
any records of work conducted on this type of specific phobia in Indian subcontinent 
and it favours my interest to work on BII phobia in general population. Studying the 
BII in general population has great significance, because of its grave implications for 
the health related poUcies. It is evident from the previous studies that BII phobic 
individuals avoid essential medical care's and other life saving surgeries, medications 
and avoids visiting hospitals and the very foremost thing is that they do not want to 
expose themselves as blood phobic which favour them to avoid other medical 
prescriptions. Mental illnesses are present almost in every population and every 
person almost gets mental illness at one or other part of his life at least once. 
One of the major problems with BII phobic is with the patients, whose BII phobia 
coincides with other medical problems like diabetes, cancer or other disease, which 
needs an essential life saving surgery. Diabetic patients often need insulin injections 
to keep their glucose level in control and however if the case would be such that its 
diabetic problem coincides with that of BII phobia the patients restrain from receiving 
insulin injections or avoid other medications. 
According to a report published by a Indian daily news paper Hindustan Times on 
14 of November 2012, over 10 lakh people in India will die due to diabetes and its 
complications by the end of this calendar year, an International Diabetes Federation 
(IDF) report has stated in a statement issued on the world diabetes day, by IDF 
president Jean Mbanya that a recent IDF report has suggested India has 6.13 crore 
people living with diabetes, second only to china. Moreover, nearly 60% of diabetics 
in India have never been screened or diagnosed due to lack of awareness and which 
may partly be because of having phobia of blood or injections which restrain from 
visiting hospitals. More than 32 million diabetics in India- India is the "diabetes 
capital" of the world-responsible for 19% of the worldwide incidence in diabetes in 
2005; projected to increase to 22% by 2030. 
India continues to contribute about a quarter of all global maternal deaths. Globally, 
every year over 500,000 women die of pregnancy related causes and 99% of these 
occur in developing countries. In India as many as 49 % of the pregnant women still 
do not have three antenatal visits during pregnancy partly this may be because of 
having blood injection and injury phobia whose patients avoid visiting hospitals. 
A report published by India today in 2010 august that, cancer is the second biggest 
cause of death in India, in 1991, six lakh new cancer cases were diagnosed, that figure 
has now risen to eight lakh. 
Regarding such disastrous reports of maternal deaths, diabetes and cancer in India, 
there are no reports of research on blood injection and injury phobia which however 
may be the primary reason for not visiting the hospitals, avoiding medical checkups 
and tests and other medical procedures. So there is an exigent need to research on 
mental disorders like the one discussed above which can be used to initiate new 
health policies nationwide and worldwide, and to anticipate early targeted 
interventions for controlling these disastrous illnesses which will help the nations to 
grow economically and healthily. 
AIMS AND OBJECTIVES OF STUDY 
The present study aims to assess: 
1. Whether Genetic or Environmental effects are of similar magnitude in the 
etiology of phobic disorders in the general population samples. 
2. Whether the genetic risk factors are same in the population samples. 
3. How much consistent are the results obtained across different diagnostic 
approaches to Blood phobia in the general population sample. 
4. To understand the mode of inheritance, age of onset and prevalence of the blood 
phobia. 
5. Is there any gender specific effect in the inheritance and prevalence of blood 
phobia? 
6. Are there quantitative differences in the role of genetic and environmental risk 
factors for blood phobia in males and females? 
7. Are there quantitative differences in these risk factors, i.e., could the Genetic or 
environmental influences on phobia in males differ fi-om those which act on 
females? 

REVIEW OF LITERATURE 
Anxiety disorders are highly prevalent and disabling class of psychiatric disorders. 
This is the most prevalent class of psychiatric disorders in the U.S. (Kessler et al., 
2005) and many other coimtries (Alonso & Lepine, 2007) anxiety and depression 
often occur together and until the last part of the 19th century, anxiety disorders were 
not classified separately firom other mood disorders. It was Freud (1895 b) who first 
suggested that cases with mainly anxiety symptoms should be separated under name 
of "Anxiety neurosis". 
During 1970s, three anxiety disorders were recognized and were considered to be 
under the rubric of "Phobia neurosis", "obsessional neurosis" and "Anxiety neurosis 
which include panic attack. The DSM then prepares the complete manual for the 
recognition of these mental disorder and classification of anxiety disorders according 
to its latest version available (DSM-IV-TR) are given in the introduction part of this 
dissertation. 
Anxiety disorders are associated with serious disability (Alonso and Lepine 2007, 
Kessler, 2007) increased rates of chronic medical conditions and high rates of 
comorbidity and phenotypic overlap with a variety of neuropsychiatric conditions 
(mood and substance abuse disorders in particular (Scott et al., 2007) 
Anxiety, both as a symptoms and a syndrome is frequently reported by children and 
adolescent. Community based studies have found that anxiety disorders are to be one 
of the most prevalent psychiatric disorders (Kashani and Orvaschel 1990, 1988). For 
the sake of convenience here only the overview of specific phobia and then blood 
injection and injury phobia is given. 
Studies on Phobia: 
Phobias are relatively common in the general population. An extensive survey found 
a rate of 5.9 phobias per 100 people with women having a sustainably higher rate 8.0 
than man, 3.4 (Mayers et al., 1984). A phobia must also be distinguished from a fear 
or anxiety. Agoraphobia appears to be the most frequent phobia (Agras et al., 1969). 
Costello (1982) studied fears and phobias in women only and found that 74% of the 
women reported having one or more fears. In contrast, situational phobias seem to 
have little or no genetic component. In a subset of the sample, blood injury phobias 
resembled situational phobias in having greater evidence for environmental than 
genetic etiology (SmoUer et al., 1998), although familial aggregation of blood injury 
fears appeared to be due mainly to additive genetic factors (Neale et al., 1994). 
Many people have turned to the brain in order to understand the biological circuitry 
behind phobias. The amygdala an almond shaped nuclear complex that is located in 
the dorsal mechanical portion of the temporal lobe, has been proved to be intricately 
tied in with the brains perception of fear. A portion of the amygdala known as the 
lateral nucleus is particularly responsible for fear responses. The amygdala receives 
different projections from such areas as the olfactory system, the hypothalamus the 
cerebral cortex and the brain stem there are many more circuits from the amygdala to 
the prefrontal cortex than the outer way around causing us to have so little control 
over our fears (Adolphs et al., 1995; Davis 1998; Labar et al., 1998). 
Le Doux (2000) proposed a hypothesis regarding lesions of the amygdale central 
nucleus interfere with energy measures of confroUed fear including physiological and 
behavioural responses. There is evidence that amygdale and hypothalamic damage 
may be the cause of phobias. For instance phobic children are bom with a decrease in 
the activation of neurons in their amygdale and hypothalamic region. Anomalies in 
the hippocampus and prefrontal cortexes may also be the cause of phobias. Damage 
to the hippocampus has a strong effect on memory, and thus could cause on 
individual to incorrectly remember a fearfiil event. The prefrontal cortex is associated 
with the phenomenon of extinction, the weakening of the fear response to a 
conditioned stimulus over time. Thus, damage to this region could allow for the 
persistence of a fear response to years after an initial encounter with stimulus 
(Miranda white, 2002). 
Twin Studies on Phobia: 
Several twin and family studies have suggested that major depression is genetically 
distinguishable from panic and phobic disorders (Weismann 1993; Biederman et al., 
1991; Kendler et al., 1993). Twin and adoption studies help address the equation of 
whether the familial nature of phobic and panic disorders is due to genetic influences 
by comparing concordance rate of monozygotic and Dizygotic twins, one can 
estimate the heritability (Proportion of phenotypes variance due to genetic factors) of 
these disorders, although this estimate will vary depending on the population studied 
(Torgerson S., 1983). Situational phobia e.g., (driving, flying, enclosed places) are 
more closely related to agoraphobia than are other specific phobia (Martin et al., 
1997). The strongest history of all anxiety disorders is seen in blood injury phobia 
(Marks 1986). 
Family studies suggest that phobias are familial (Noyes et al., 1986, Fyer et al., 1990; 
1993; 1995; Stein et al., 1998) and twin studies of self report fears consistently 
suggest etiological rate for genetic factors (Torgerson, 1979; Rose et al., 1983, Rose 
and Ditto, 1983; Philips et al., 1987). Twin studies also support a role of genetic 
factor in phobia subtype (Carey and Gottesman, 1981; Torgerson, 1983; Kendler et 
al., 1992a, 1999a, 2001a, Sure et al., 1993; Neale et al. 1994a). Most of the studies 
have consistently suggested important sex differences in the frequency of irrational 
fears and phobias (Bourdon et al., 1988; Kessler et al., 1994, Frederieson et al., 1996; 
their critical presentation and their risk factors (Cameron and Hill, 1989; Weinstock, 
1999). Twin studies clarify the impact of sex on both genetic and familial 
enviroimiental risk factors (Kendler et al., 2003). 
BLOOD INJURY INJECTION PHOBIA 
Blood injury injection phobia involves an intense fear of situations, in which an 
individual is directly or indirectly exposed to blood, injections or viewing injuries, 
along with a tendency to avoid these situations. Blood injury phobia is classified as a 
subtype of specific phobia in the ciirrent edition of the diagnostic and statistical 
manual of mental disorders (DSM-IV-TR, APA 2000). 
Sufferers report fear on exposure to a specific class of stimuli that include blood, 
injury, injection, etc. They also avoid or endure or tolerate such exposure with 
distress, identifying the associated fear and avoidance as excessive or irrational. In 
contrast to the case in other specific phobias, 4 out of 5 people with blood injury 
phobia faint in phobia situation (GST, Lindahl, Sterner, and Jerremalm, 1984; Thyer, 
Himle, and Curtis, 1985). Connolly, Hallam and Marks (1976) drew attenfion to the 
specificity of fainting when they found that only 0.2% of mixed phobias reported 
such fainting this "emotional fainting" or vasovagal syncope (Callahan, Edelman, 
Smith, & Smith 1963; Graham, Kabler, and Lunsford 1961, Lewis, 1932, Poles and 
Boycott 1942; Ruetz, Johnson, Callahan, Meades & Smith, 1967). Occurs when blood 
pressure drops dramatically following an initial increase, apparently as blood is 
directed toward skeltal musculature. The redirection of blood is witnessed by 
increasing facial pallor. Breathing rate may temporarily increase and become shallow. 
Individuals report feelings of heat, dizziness, confusion, nausea epigastric discomfort, 
yawing, and may lose consciousness. Respiration becomes slow and deep and 
sweating is almost inevitable. Recovery is slow leaving persons weak, inert and pale 
with heart rate and blood pressure remaining suppressed. 
A primary difference between blood injury phobia and other specific phobias 
involves the physiological response to phobic stimuli, specifically, many individuals 
with blood injury phobia denote experience the traditional fear response of 
heightened sympathetic nervous system activity demonstrated by increase in heat rate 
and blood pressure upon exposure to blood injury injection related stimuli. Instead 
many individuals with blood injury injection phobia experience a diphasic response 
when they are confi-onted by the object (Graham, Kasler and Lunsford, 1961). The 
diphasic response consists of an initial phase which resembles the traditional fear 
response, in which heart rate and blood pressure drop rapidly and in many case, 
fainting occurs as the individual loses consciousness (e.g., Connolly, Hallam and 
Marks, 1976, Cohn, Kron, and Brady, 1976, Wardle & Jarvis, 1981, Curtis and Thyer, 
1983, Ost, sterner and Lindahl 1984). 
Blood injury injection phobia is virtually the only specific phobia, and the only 
anxiety disorder, in which fainting occurs, and it has been estimated that as many as 
70% of the individuals with blood injury injection phobia have fainted at least once 
upon exposure to blood injection injury stimuli (Ost, 1992). It is important to note 
that there are individuals who met diagnostic criteria for blood injection injury phobia 
and donot have a history of fainting. In Ost (1992), one of the most comprehensive 
studies of blood injury injection phobia, 30% of blood phobics and 44% of injection 
phobics who met diagnostic criteria for blood, injection injury phobia reported never 
having fainted in the phobic situation. 
The stimuli that individuals with blood injury phobia avoid or find distressing at first 
inspection suggest commonality, but more detailed analysis reveal some distinctions 
listings of feared situations include a group of items that involve blood, mutilation, 
injury, injection, medical paraphernalia, medical or dental environments, and illness. 
It is possible to separate these related items into two groupings. Kleinknecht (1988) 
examined the correlations between the mutilation questionnaire (MQ) (Klorman, 
Hasting Werts, Melamed, & Lang, 1974) and fainting in a student sample, while 
partialling out the variance attributable to fear. They identified that the MQ 
comprised two independent components. One component relating to general blood 
and injury fears and another to fainting in the presence of blood and injury. Two 
different response patterns characterize blood injury phobia. The first set of changes 
is the classic fight or flight response (Cannon, 1927) which is common to all phobic 
disorders (Andrews, Crime, Hunt, Lampe, 1994) Page, Barlow, 1988, Gray 1987). 
Persons report feeling and become physically aroused in preparation for flight or 
fight. 
Epidemiology: 
It is not possible to estimate accurately the prevalence of blood injury phobia because 
no study had adequately assessed the firequency of blood and injury fainting in 
addition to fear nevertheless it is possible to estimate that the fi-equency of fainting in 
the presence of blood and injury is between 5% and 15%. By way of explanation 
between 13% and 19% of late adolescents report fainting in the presence of blood or 
injury (Kleinknecht, 1987; 1988; Kleinknecht and Lenz, 1989). To the extent that 
there figures accurately reflect the lifetime prevalence of blood injury fainting in a 
population sample, they indicate an upper boundary of prevalence. An indication of 
the lower limit of fainting in the blood presence by blood and injury phobics can be 
drawn fi-om the rate of fainting in blood donation units that is around 5% (Callahan et 
al., 1963 Poles and Boycott, 1942). Because people who anticipate fainting in medical 
situations may avoid these contexts and because observed fainting rates assess point 
prevalence rather than lifetime prevalence, these figures represent a lower boundary 
of the occurrence of blood injury fainting (Page 1994). 
In a study by Ost, 81 patients with blood phobia were compared with 59 patients 
suffering from injection phobia. There were no differences between the two age 
groups in the age of onset, age at treatment, marital and occupational status, history of 
fainting in the phobic situation and impairment. Higher proportions of the blood 
phobic subjects reported having a first degree relative with the same phobia compared 
with those with injection phobia. The similarities were more marked than the 
differences and the authors suggested that these two specific phobias should be 
regarded as one diagnostic entity (Ost 1992a). 
There is great range in the prevalence values reported in the literature for specific 
phobias as a general class, as is evident fi-om the data of Serrano Blanco et al., (2010) 
6.6%, Becker et al., (2007) 9.9% (women only). Wells et al., (2006) 7.3%, Kessler et 
al., (2005) 15.7% (women only), Fredriksson et al., (1996) 19.9% Kendler et al 
(1992) 20.5% (women only), Robins et al (1984) 8.5-25.9%, Agars et al. (1969) 
7.7%. Among 184 teenaged maternity patients, 22% were found to have a fear of 
blood drawing strong enough to make it hard to come to a public clinic for prenatal 
care (Cartwright et al., 1993). Li a hospital based study, 30.1% of 273 patients and 
19.5%i of 1263 healthy people reported fear of blood and injections. 
The global population rates do not give any information about changes in prevalence 
at different ages. Development studies point to a general trend for blood and injury 
fears to rise in early childhood and subsequently decrease with age. Mild blood injury 
fears have been found in 44% of 6 to 8 years old but only 27% of 9 and 12 years old 
(Lapouse and Monk; 1959). Estimates of the prevalence of blood injury phobia show 
a similar pattem, rising to 13% by age 10 and decreasing progressively until age 60 
with a mean age of onset at age seven (Agras et al., 1969; Ost et al., 1984). 25% of 
the university students who reported fainting avoid consultations with doctors 
(Kleinknecht and Lenz, 1989). 
Etiology: 
The inclusion of blood injury injection phobia within the category of specific or 
simple phobias in classificatory systems reflects a perception that fears has a primary 
role in the disorder. Consistent with this assumption, blood injury phobia appears to 
share a common etiology with other phobias. Most reports of specific phobias include 
a history of negative experience of the feared situations but also other psychological 
cause as well as biological and genetic factors are described (Davey et al., 1993, 
Menzies and Clark 1995). 
Another early interpretation was presented by Freud who considered phobias to be a 
defense against internal anxiety. By transforming the intemal anxiety to an external 
one, the anxiety could be avoided. The content of the phobias was considered to have 
a symbolic meaning related to unconscious anxiety (Freud 1932).Page formulated a 
theory that explains blood and injection phobia as a product of two separate but 
related etiologies; the first is an underlying fearful avoidance that may involve 
elevated trait anxiety, the second fainting, that may involve elevated disgust 
sensitivity. It has been suggested that the anxiety in blood and injection phobia is 
related to disgust to a greater degree than the fear (Page 1994). Disgust is a 
fundamental emotion defined as "revulsion at the prospect of (oral) incorporation of 
an offensive object". 
Blood and injections can elicit both fear and disgust and it seems that disgust 
increases with greater distance from the body. Discomfort on seeing one's own 
menstrual blood or handling red meat has not been reported in the blood and injection 
phobia literature (Marks 1988). 
Physiologically, disgust is typically associated with parasympathetic activity and 
reduction in diastolic blood pressure leading to fainting sensations (Page 2003). In a 
classic study by Hebb, a realistic plaster replica of a severed chimpanzee head was 
placed in a cage of live chimpanzee. The animals were observed to go into paroxysms 
of terror despite their lack of prior experience with such a stimulus. From these 
results Hebb suggested that there is a heritable component in blood phobia (Hebb 
1946). In a study by Ost, sixty one percent of the blood and injection phobic's report 
that one of their first degree relatives also has the same phobia (Ost 1992a) and both 
the vasovagal reflex and the blood and injection phobia strongly tend to run in the 
family (Hamilton 1995). 
The tendency to faint could be more highly heritable than the tendency to become 
afraid or feel disgust. This could produce higher heritability for blood and injection 
phobia with a history of fainting than for other phobias in general. 
Twin studies are one way to study the contribution of genetic and environmental 
factors for developing a condition. If it is observed that monozygotic (MZ) twins are 
more similar then dizygotic (DZ) twins with regard to a specific condition it is usually 
considered to be evidence of a hereditary background for the condition concerned. 
There is an extensive literature including several landmark twin studies which 
supports the theory that the familial resemblance is genetic (Torgersen, 1979, Rose 
and Ditto 1983, Kendler 1992, Neale et al., 1994, Kendler et al., 1999, Kendler et al.. 
2001). First degree relatives of persons with specific phobias also generally report a 
threefold increase in incidence when compared to the general population (Villafuerte 
and Burmeister 2003). 
In 1977, Rachman described the conditioning theory of fear and avoidance. The 
theory states that anxiety is a conditioned response (CR) that is elicited in the 
presence of a conditional stimulus (CS). When elicited the CR influence behaviour 
that avoids or escapes the situation. This behaviour reinforces through the fact that the 
anxiety disappears because of that behaviour. In 1977, Rachman proposed that there 
are at least three different pathways of acquisition to the phobia for blood and 
injections. 
a. Direct learning or conditioning (emergency treatment or forced treatment in 
childhood). 
b. Observational learning (watching others showing signs of fears in a particular 
situation). 
c. Informational learning (hearing or read that the situation is dangerous) (Rachman 
1977). 
With respect to specific activating events, conditioning is one way that stimuli 
become able to elicit anxiety (Rachman, 1991 and Thyer et al. 1985) identified a 
conditioning episode when a "patient received an injection at age 13 and fainted" and 
in another person when "at age six she heard her elementary school teacher give a 
talk on the circulatory system. This fiightened the patient to the point of syncope" 
(Thyer et al. 1983). One study reports that 46% had conditioning experiences, 32% 
observational learning and 9% informational learning of how individuals with blood 
and injection phobia had acquired their illness (Ost, 1985). In another study by Ost 
the majority (52%) of the patients with blood and injection phobia attributed their 
onset to conditioning experiences, while 24% recalled observational learning, 7% 
informational learning and 17% could not remember any specific onset circumstances 
(Ost 1991a). The corresponding figures from another report are 76% with 
conditioning experience, 20% recalled observational learning and 3% information 
leaning as being primary in their fear outset (Kleinknecht 1994). The result are based 
on memories reported by the study population and these memories indicate traumatic 
conditioning like experiences are the predominant path away to developing blood and 
injection phobia in those population. The foremost problem with this strategy is the 
obvious rise of memory distortion that can take place since the onset took place years 
earlier. It is not known why some individual that have been exposed danger or 
impleasant situations develop a phobia, while others do not, despite having had the 
same experiences. Another question to be answered is why some individuals develop 
a phobia at a certain point in time, after experiencing a traumatic event or not, but did 
not develop it earlier after events that were as traumatic as, or even more traumatic 
than the current one. 
It has been speculated that the most serious form of blood and injection phobia might 
be acquired through conditioning. But in two studies no relationship between ways of 
acquisition and anxiety components was found, nor did conditioning and indirectly 
acquired phobias differ in severity (Ost 1991a, kleinknechtl994) 
Emotional Fainting: 
It is common phenomenon to experience a drop in blood pressure when exposed to 
needles, injections or surgery, but not to the degree that a phobic person experiences. 
Fainting in the presence of blood and injection stimuli is relatively common among 
late adolescents; 13-19% (Page 1994), while fainting is observed in 8.0% of high 
school students and 2.6%» of adults who donate blood (Newman 2003). Not all of 
these individuals will meet the criteria for blood and injection phobia, fear is neither 
necessary nor sufficient for fainting to occur blood and injection phobia is the only 
phobia associated with fainting in the feared situation. Around 70-80%o of the persons 
with blood and injection phobia faint when exposed to the phobic stimuli (Ost et al., 
1984, Thyer et al., 1985, Ost 1992a, Olatunji et al, 2006). Persons with blood and 
injection phobia with a history of fainting experience, generally report higher overall 
level of fear than those without fainting history (Kleinknecht 1987, Kleinknecht 
1988). 
The fainting reaction is a vasovagal syncope and has been described as a two-phase 
(biphasic, diphasic) response to a blood and injection phobia stimuli. Various 
explanations exist regarding the trigger mechanisms. It has been suggested that the 
first phase is a preparation for a flight and fight reaction but that the social context 
does not make that possible. The second phase, in individual's suffering from blood 
and injection phobia is an over activation of the parasympathic nervous system which 
is trying to compensate for the first phase. Disgust can also activate the 
parasympathic nervous system and make the response to the sympathetic nervous 
system even stronger. Both reactions are active strategies for coping with stress. The 
initial phase involves an increase in heart rate, blood pressiore and skin conductance. 
The second phase involves an increase in heart rate, blood pressiire and skin 
conductance. The second phase evolves Bradycardia and hypotension leading to 
reduced cerebral blood flow and ultimately fainting. The redirection of blood towards 
skeletal musculature is made evident by an increase in facial pallor. 
The vasovagal reflex usually appears 5 to 30 minutes after the exposure to the phobia 
stimuli but it can take several hours before the reaction comes. Unconsciousness 
usually lasts for only a few seconds but it can last fi-om 10 minutes to 2 hours. The 
blood pressure returns to normal within 2 hours. Recovery is rather slow leaving the 
persons weak, but most of those who faint can resume normal activity within several 
hours. Others can have anxiety, malaise and weakness for 1 -2 days. 
Comorbidity: 
Comorbidity in psychiatry is generally a rule rather than exception. Comorbidity 
between specific phobia and other psychiatric disorders is relatively high and tend to 
co-occur with generalized anxiety (Brawman - Mintzer et al., 1993, Magee et al., 
1996), posttraumatic stress disorder (Goisman et al., 1998) and with other anxiety 
disorder (Kessler et al, 1994). Borkovec et al., (1995) found a specific phobia in 40% 
of patients with generalized anxiety. 
In addition, individuals fi-equently experience more than one specific phobia (Curtis 
et al., 1998). Multiple phobias were reported by 5.4% of the females and 1.5% of 
males in a study with 704 persons between the ages of 8-70 years (Fredriksson et al., 
1996). In the study by Bienvenu the individuals with blood and injection phobia had 
higher than expected lifetime prevalence of other psychiatric conditions, including 
marijuana abuse / dependence, major depression, obsessive compulsive disorder, 
panic disorder, agoraphobia, social phobia and other simple phobias (Bienvenu and 
Eaton 1998, Park et al. 2013). These findings are similar to what Neale et al. detected 
in a population based study of female twins (Neale et al, 1994). In a study by Becker 
et al., the only mental disorder associated with blood and injection phobia was 
anxiety disorders with an odds ratio (OR) of 5.24 confidence interval (CI) 2.59 -
10.60 (Becker et al., 2007. Another examination of the relationship between simple 
phobia and physical disorder showed that there was an increased risk for respiratory 
disease (Goodwin et al., 2003). 
This Comorbidity is also prevalent in pregnant womens as shown by many studies, 
18% of 428 pregnant women (6 week post partum's) were found to have psychiatric 
disorder, by using the structured clinical interview for DSM-IV (Navarro et al., 2008). 
The prevalence of antenatal anxiety during the third trimester is reported to be 
between 10% and 24% and it's also overlaps with depression and increases the risk of 
postnatal depression (Sutter - Dally et al., 2004, Heron et al., 2004). 
Anxiety symptoms during pregnancy are associated with depressive symptoms, stress 
and low self esteem (Littleton et al., 2007). 
Neuroimaging: 
There is considerable ne\irophysiologic evidence showing that the central nervous 
system is disorganized in the phobia state, positron emission tomographic (PET) brain 
studies suggests that areas of the brains that performs emotional, cognitive 
subconscious and cerebral association functions, such as parts of the Paralimbic, 
subcortical, nuclei, right amygdale, right orbito-fontal cortex, anterior temporal cortex 
and anterior cingulated areas of the brain mediate symptoms in phobia and different 
anxiety disorders (Ranch et al., 1997, Fredrikson and Furmark 2003). Regional 
cerebral flow is also deranged or decreased in these areas of the brain during phobic 
provocation (Rauch et al, 1997, Fredrikson et al., 1997, Fredrikson & Furmark 
2003). 
One magnetic resonance imaging study was examined the effects of symptom 
induction on neural activation in the brain in persons with blood and injection phobia. 
Diminished medial prefrontal cortex (MPFC) activity was observed. The MPFC has 
been shown to be critically involved in the automatic and effortful cognitive 
regulation of motions. These results could therefore reflect reduced cognitive control 
of emotions in persons with blood and injection phobia (Hermann et al., 2007). 
Impairment and Consequences: 
Having blood and injection phobia is surely a health care problem and many 
individuals first become aware of blood and injection phobia after a negative 
experience in the health care environment. This lesson leamed often becomes 
generalized and may then include all situations and objects associated with the first 
fear (Hamilton 1995). BII fearfiil subjects displayed the usual defense response when 
exposed to a non-feared threatening stimulus (Jaun et al. 2012). 
People suffering fi-om blood and injection phobia possess a heightened risk of 
morbidity and mortality simply because they avoid health care, sometimes for many 
years (Kleinknecht and Lenz 1989, EUinwood and Hamilton 1991). Most likely there 
is a minor fi-action (<1%) of the individuals with blood and injection that never visit 
hospitals (Agras et al, 1969). 
Blood and injection phobia can delay prenatal care including laboratory procedures 
(Dennis 1994, Langslow 1998) and could therefore have serious implications. The 
blood and injection phobic person will be an expert of avoiding treatment and 
hospitals. A development of so called "safety behaviours" (e.g., avoid getting, 
pregnant, being vaccinated or operated on in case of blood phobic womens) which 
can help to maintain the fear. People with blood and injection phobia tend to interpret 
situations in such a way as to maintain or increase their anxiety for blood and 
injection. In a sample of 111 persons with blood and injection phobia, 32% said the 
phobia had a negative consequences concerning their career choice, work and 
education, 9% said that they would not be able to help other people if they got injured 
(especially their children), 8% completely avoided visiting hospitals and getting 
medical check-ups, 8% did not go to the movies, 7% said they were generally worried 
and avoided various situations and 2% did not dare to become pregnant. 33% stated 
no direct negative consequences, even if they were distressed by their phobia (Marks 
1988, Magee et al., 1996, Davey 1997). Therefore blood injury and injection may 
cause major social difficulties in life. A fear of blood testing or immunization can 
interfere with or even destroy plans for travel, education, immigration or 
employment. Students with blood and injection phobia may not choose careers in 
nursing or medical areas. 
Blood and injection phobia can also be fatal. There are reported deaths ascribed solely 
to the phobia and its vasovagal reflex during needle procedures such as 
venupunctures, blood donation, arterial puncture, pleural tap, and intramuscular and 
subcutaneous injections (Hamilton 1995). Enquiries into the causes of maternal 
deaths in the United Kingdom indicate that women with injection phobia are at risk 
when exposed to anesthesia (Lum Hee and Metias 2001, Copper and McClure 2005). 
Bienvenu foxmd in his study from 1998 that the individuals with blood and injection 
phobia did not differ with regard to regular care for specific medical conditions, 
n\imber of outpatients visits or hospitalizations or live births (Bienvenu and Eaton 
1998). Diabetic patients suffering from blood and injection phobia had higher than 
expected rates of macrovascular complications. Other studies have also shown that 
diabetic patients with blood and injection phobia had less frequently performed self 
monitoring of blood glucose (Metsch et al., 1995) and had poorer glycaemic control 
(Marks 1988, Page 1994, Berlin et al, 1997). 
Treatment: 
Specific phobias are most readily freatable of anxiety disorders. The treatment of 
choice for these phobias is a type of cognitive behavioral therapy also called 
systematic desensitization or exposure therapy (Chambless 1990, Von Knorring et al., 
2005). This treatment is very effective. According to the US National Institute of 
Mental Health about 75% of people are able to overcome their phobias through 
cognitive - behavioral therapy. There is another method for the treatment of blood 
and injection phobia developed by Ost and sterner (1987) called as Applied Tension 
(AT). This method takes advantage of the unique characteristic of a biphasic 
physiological response when an individual with blood and injection phobia is exposed 
to phobia provoking stimuli. The individual first learns to recognize the early signs of 
a decrease in blood pressure and then is taught to practice exerting muscle tension. 
The tension technique is often combined with a gradual exposure to blood and 
injection phobic stimuli (Peterson & Cigrang 2003, Choy et al 2007, Lauren et al. 
2012). Some researchers have demonstrated efficacy for the treatment of BII phobia 
with the techniques like applied tension and applied relaxation. Ducasse et al. (2012). 
There is also a cream called as EMLA^ ^^  (Eutectic Mixture of Local Anesthetics) 
which is eutectic mixture of Lidocaine and prilocaine that is liquid at room 
temperature even though both Lidocaine and Prilocaine are room temperature solids. 
EMLA must be applied at least one hour before needle procedure is implemented and 
it works quite well for most people whose blood and injection phobia is triggered by 
the sensation of the needle penetrating the skin and vein. Drugs are also used but are 
not recognized as a standard treatment for specific phobia and the general view is that 
medication has little to benefit in reducing a specific phobia (Choy et al., 2007). For 
preoperative management of patients with needle phobia midazolam is the most 
preferred benzodiazepine for anxiolytics because of its rapid onset and short diiration 
of action (Bamgbade 2007). However the use of stress reducing medical devices e.g. 
decorated syringes (flowers, musical notes) can effectively and significantly reduce 
aversion, anxiety, fear and overall stress among both children and adults (Kettwich et 
al., 2007). 
hi blood injury injection phobia, the distress and the impairment associated with the 
phobia can lead the individual to avoid getting necessary medical or dental attention 
due to the likelihood of having blood drawn or receiving injections (Ost and 
Hellstrom, 1997). Thus obtaining more knowledge about the nature, origins and 
treatment of blood injury injection phobia can be crucial to improving and even 
extending the lives of those who suffer fi-om this disorder. 
The fear of blood and injection was higher among patients with chronic disease and 
also among individuals with lower levels of education (Kose and Mandiracioglu 
2007). A negative association of BII Phobia and education in a recent study was 
found (Park et al. 2013). The prevalence of blood and injection phobia is probably 
lower in population samples fi^om clinics and hospitals since those with this phobia 
tend to select themselves out of such populations. Therefore the studies done in those 
populations probably underestimate the true prevalence and showing the variable 
results. Therefore we decided to study BII phobia in the general population. 
Research into health consequences may seem unwarranted at first. Whereas 
avoidance of blood, injection, and injury may limit a person's life, it is not dangerous. 
However phobia avoidance becomes serious when it precludes an individual securing 
appropriate medical care. When a potentially life threatening conditions co-exists 
with blood injury phobia, it is irrelevant how effective available treatments for the 
diseases are the irrational avoidance may circumvent the entire treatment process. To 
reduce the incidence of such compHcations it is necessary to identify the etiology of 
the disorder and ultimately to develop and refine effective treatments. 
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METHODOLOGY 
Psychiatric genetics is the field of study that examines the role of genetics in human 
behavior. Often associated with "nature versus nurture" debate it is a highly 
interdisciplinary field, involving contributions fi-om Biology, Genetics, Ethology, 
Psychology and Statistics and is an emerging discipline in neurosciences that deals 
with the inheritance of behavioural traits. In animal studies, breeding, transgenic and 
gene knockout technique are common techniques for studying animal behavior, but 
these techniques could not be applicable on humans. Due to these limitations, 
information regarding human behaviour is gathered by using the common research 
methodologies like population studies, family studies (i.e., close relative analysis, 
pedigree analysis etc.) and twin studies and adoption studies. 
For the present study a survey was conducted in the Aligarh region from its five 
prominent places 1) Maulana Azad Nager 2) Hamdard Nager and its adjacent areas 3) 
Logo Colony and its adjacent areas 4) Firdous Nager 5) Doharra maffi and Sir Syed 
Nager. The data generated by pedigree studies from these five places are then grouped 
as pedigree group 1 to pedigree group 5 in the data tables (tables T 1 to table T 10). 
These are also referred to as Sample 1 to Sample 5. 
POPULATION STUDIES 
In population studies, prevalence and incidence rates of mental and other disorders 
derived from general population surveys have important scientific and health policy 
implications. Variations in such rates can provide clues to possible causes and can be 
used as base rates for corporative purpose in genetics. In the present work the general 
survey among the population was conducted and a sum of 3261 Participants from 
general population was evaluated for blood, injection and injury phobia (from 
probands and relatives of probands) by a precede semi-structured interview based 
questionnaire having a value for Chronbachs a equal to 0.972 which shows the highly 
internal consistency among the items of the questionnaire. 
FAMILY STUDIES 
Pedigree Analysis 
The observation of some disorders aggregate in families serves as prerequisite 
evidence suggesting a possible genetic component. The basic family study approach 
involves identifying individuals with a particular psychiatric disorder (the proband) 
and then determining the rates of disorder in the probands relatives. 
The family study reveals the familial nature of a disease / disorder, its mode of 
inheritance, the range of clinical or phenotypic expression within the family and the 
inter-generational difference resulting from family dynamic genes and environments. 
The classic family study design requires the collection of a large sample of cases or 
probands, followed by systematic evaluation of relatives. 
A proper collected family study is valuable for many kinds of studies. Studies of rates 
of illness among relatives can help to define the trait or disorder as heritable or non-
heritable, autosomal and sex linked and also its phenotypic spectrum, i.e., 
recessiveness or dominance, complete / incomplete penetrance, variable or full 
expressivity etc. Therefore the subjects for the present study were informed about the 
goals of the study and a verbal consent was taken (in most of the cases the interview 
was conducted face to face). 
Interviewing is of a central importance in medicine, it is core skill in clinical psycho-
genetics too. We practiced in the study a semi-structured diagnostic interview 
includes an assessment of patients psychopathology including not only the formal 
mental status testings which may be conducted but also the influences and 
conclusions which an interviewer draws as the interview is conducted. We also asked 
the question to frame the frankness to sufferers to narrate their earlier stories 
regarding their phobia) to elicit the history of the disorder by inviting the proband 
(and sufferer relatives) to give a narrative description of the course and chronology of 
his or her symptoms i.e., how did the disorder began, was the onset sudden or gradual, 
what was the age of onset, etc. The information gathered in this way helped us not 
only to assess the presence or absence of the patients frait but also to gather 
information regarding his family, work setting, friends and other relationships which 
were affected by his or her illness. The diagnosis of phobia type was also complete 
using the questionnaire based on DSM-IV diagnostic criteria. All the patients chosen 
for the present study satisfy DSM-IV-TR criteria for Anxiety disorders. A proband 
was selected and the questionnaire based on DSM-IV-TR (2000) diagnostic criteria 
administered to the patients for confirming diagnosis. These probands, and all 
available first, second and third degree relatives were personally interviewed as far as 
possible, using a selected format questionnaire having Chronbachs a equal to 0.972 
which is considered excellent for the high internal consistency of the questionnaire 
items. 
The associated disorders and behavioral patterns were also measured using the family 
history, gender differences, developmental mile stone, education etc. Variables related 
to illness and treatment (e.g., age of onset, medication rates of specific symptoms and 
variable related to physical health) etc. were taken from each of the subject separately 
and in detail. The questionnaire involved 22 items for BIT phobia and six demographic 
items. If a fear of blood, injury or injection was reported, a series of question was 
asked to ascertain whether the fear met the criteria for phobic level response. If the 
participant assured "No" to the phobic questions and mentioned that the fear did not 
interfere with usual or routine life activities, the phobic status was not given to the 
person, however if the answer was not "No" and the person mentioned that the life 
was affected due to the avoidance behavior, a phobic status, was given and it was 
considered a sufferer case and was recorded in the list of sufferers. Appearance, 
psychomotor behavior and to some extent emotional state could be judged through 
visual inspection during the interview. As far as possible every proband and his or her 
sufferer relative was contacted personally and besides interviewing, we also showed 
them the pictures, paintings or photographs of the things and situations of which they 
were foimd to be afraid of (e.g., those who reported to be blood phobic, pictures of 
injured people, bleeding wounds, were shown to the respondents of blood phobia. To 
confirm whether the patient is having simple fear or that he/she was a confirmed 
phobic of those things or situations. Thus these pictorial stimuU served as conditional 
stimuli to provoke an irrational fear in the real phobic patients for fiirther testing, by 
observing patients reaction and conditions i.e., (sweating, pale faces, shivering, 
increased heart beats, fast pulse rate and deep heavy breathings etc.) We confirmed 
considerable number of cases for the presence or absence of the disorders, using this 
provoking conditional stimulus. 
Raw data from all available subjects were utilized, with the help of raw data pedigrees 
were constructed up to three or four generations (depending upon the availability) to 
draw the conclusions about the mode of inheritance and prevalence of the disorders. 
Attempts were also made to find out the possible causes of the disorders, age of onset, 
most vulnerable age groups, symptomatology and the gender specific differences in 
the penetrance of the related gene / genes. 
To evaluate all the objectives mentioned in the introduction part of this dissertation, 
we assessed the family history, the life history of every sufferer, the pedigree analysis 
calculating the phenotypic ratio between sufferer and non-sufferer relative of 
probands, and the penetrance of genetic factors in the sibs of I, II, and III degree 
relatives of probands. 
A number of subjects reported having more than two types of phobias or a phobic 
condition with some other psychoneurotic disorders, such cases were covered under 
the comorbid status. 
Statistical Analysis 
In this study standard statistical tests including Chronbachs Alpha and one-way 
ANOVA were used, to examine where the differences between the groups existed. 
Chronbachs alpha of the BII phobia questionnaire was 0.972. Factor analysis of the 
BII phobia questionnaire were conducted using principal axis factoring, and varimax 
rotation. SPSS program for windows release 16.0 (SPSS Inc., Chicago, IL, USA) was 
used for all the statistical analysis. 
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t J^ame of tfie person 
a. JAge of the jyerson 
at Sex of the person 
iv. Standard of the schooC 
V. Occupation of the person (if empCbyed) 
vu JAddress 
Items Jactors 
1. JAre youphoBic ofBCood injection, injury, andneedCe? 0.923 
2. Do you avoid seeing others BCbod? 0.839 
3. Do you avoid Cooking at your own BCood? 0.829 
4. 'What is the age of onset of your BCoocCpfwBia? 0.852 
5. Do you faint at the sight of hCoocC? 0.721 
6. M what age you start getting faint at the sight ofhCoocC? 0.819 
7. "Do you avoid receiving injections? 0.821 
8. Does neecCCe size frighten you? 0.852 
9. Do yougeneraCCy avoicCgatherings ancCcrowdecCjyCaces? 0.627 
10. Vo you generaCCy feeC that heart rate is increased in 
phoBic situations? 0.831 
11. Do youfeeCsujfocation Because of fear? 0.827 
12. Do youfeeCso scared that your tongue gets driedup? 0.852 
13. V you feeCthat you Cose jnresence of vfiindinjphoBic conditions? 0.752 
14. Do you feeC chest pain inphoBic conditions? 0.672 
15. Do you feeCphysicaCweakness? 0.679 
16. Do you feeC hot flushes inphoBic conditions? 0.856 
17. Do you feeC that your mind is in numBness if you see serious oBjects? 0.721 
18. Vo youfeeCdifficuCty in respiration inphoBic conditions? 0.839 
19. Do you get disturBedBy inmgining thephoBic conditions or oBjects? 0.721 
20. Do you feeCshortness of Breath inphoBic conditions? 0.852 
21. Do youfeefsweat inphoBic conditions? 0.771 
22. Do youfeeCCxck of sCeep By imagining thephoBic conditions? 0.711 
(Extraction Method: Principal Component Analysis) 
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OBSERVATION AND RESULTS 
Five random samples from different places of Aligarh region were collected and a 
total of 167 pedigrees were constructed from these samples. These 167 pedigrees 
comprised of 3261 individuals. Out of these 1648 were male and 1613 were female 
subjects. The sufferer males were 196 (Mean 11.19%, SD±5.35) and sufferer females 
were 384 (23.36%, SD±8.18) while the normal males and females were 1452 
(88.07%, SD±5.35) and 1229 (76.06%, SD±8.18) respectively (Table T.l, T.2 and 
Histogram H.l). This data is showing a much higher percentage of sufferer females 
as compare to males in all the samples. However an overall mean percentage of 
sufferers and non-sufferers are approximately (17.78%, SE)±4.17) and (82.16%, 
SD±4.17) respectively (Histogram H. 2) 
BH Phobia expression among Generations 
Frequency of blood injection and injury phobia in the f\ 11"'' and 111"* degree relatives 
of probands was compared, the 1st degree relatives (parents, children and sibs) are 
showing highest percentage followed by III degree relatives (Grandparents, Cousins: 
Niece and Nephew) etc. and II degree relatives, (uncle aunt etc.) show comparatively 
low percentage of sufferers. Their average percentages in the sample were calculated 
from all of 167 pedigrees. The mean percentages of first degree relative sufferers of 
all probands are calculated as 26.42% (SD±8.59). The mean second degree relative 
sufferers of probands are calculated as 8.20% (SE)±8.56) while as the mean third 
degree relative sufferers of probands were calculated as 20.91% (SD±7.74) 
respectively (Table T.3 and Histogram H. 3). 
The highest percentage of sufferer first degree relatives make up this view stronger 
that this phobia has genetic basis and its components are lying somewhere in the 
genome which gets transmitted from parents to children and other category of closest 
relatives. It also shows sufficient frequency level among comparatively far (II and III 
degree) relatives, these findings strengthen the view that cause of this phobia lies in 
the genome of the sufferers. (Table T. 3 and Histogram H. 3). 
Blood phobia and fainting 
Fainting is one of the specific characters in Blood Injection and Injury Phobia; 
however there are also considerable number of BII Phobic peoples in population who 
fulfils most of criteria for this specific phobia but fainting at the sight of blood 
doesn't occur in them. Our data shows the presence of both fainting and non fainting 
subjects. The mean prevalence of fainters in our data came to be as, 55.77% 
(SD±4.30) out of these sufferers approximately 25.57%, (SE)±4.46) were males and 
approximately 74.41%, (SD±4.46) were female. The percent mean value of male 
fainting sufferers fi-om all the samples are 39.40%, (SD ±8.94) and the percent mean 
value for the female sufferers among the studied samples are 64.09 (SD ±6.49). The 
subjects among the sufferers who were non-fainters were 44.22% (SD±4.30). The 
percentage of female fainters to BII phobia is much more than the male fainters, this 
shows there is a significant difference between the male and female fainting 
individuals in relation with BII phobia. Among the non-fainting individuals which is 
44.22% of total sufferers the mean non-fainting male subjects are 60.59% (SD ±8.94) 
and non-fainting female subjects are 35.90% (SD ±6.49) (Table T, 4 and Histogram 
H. 4 and H. 5). 
Comorbidity-
Comorbidity in psychiatry is generally a rule rather than exception, a sufferer of one 
disorder is generally vulnerable to other psychiatric illnesses and this rule of 
Comorbidity with Blood injection and injury phobia is not different, but a number of 
other psychiatric disorders are also found with BII phobia in the population. Among 
the individuals of the pedigrees analyzed for blood phobia, we also analysed the 
sufferer probands for the presence or absence of other psychiatric illnesses in general 
population and a number of subjects were also found among the sufferer probands 
showing other psychoneurotic disorders, percentages of such comorbids for different 
types of disorders were also calculated for these samples and are presented in the 
(Table T. 5 and Histogram H. 6). 
The most common types of psychoneurotic disorders which were in comorbid with 
BII phobia were observed as Agoraphobia with its mean percentage 15.71% (SD 
±5.40) among the sufferers of samples (Table T. 6 and Histogram H. 6). Among the 
sufferers, 13.17% (SD ±2.76) were having Animal phobia. Panic disorder was also 
having its presence in the population with BII phobics and makes its percentage in the 
sufferers as 6.13% (SD ±2.15), however the highest percentage of the comorbid trait 
which was having its presence with BII phobia in the general population according to 
our studies was Depression which was 20.29% (SD ±3.77). The comorbid percentage 
of social phobia with BII phobia is 5.17 (SD ±1.28), there were also small number of 
sufferers of BII phobia population who also had Obsessive Compulsion Disorder 
(OCD) and its percent mean value was calculated as 2.57 (SD ±2.49). However 
34.73% from among sufferers were found not to have any co-morbid trait. (Table T. 
6 and Histogram H. 6) 
Age of onset of BII phobia 
There was a variation among the subjects with their age of onset of BII phobia. The 
average age of onset was calculated to be 9.3 years (SD±3.27) for males and 7.5 years 
(SD±2.51) for females. (Table T. 6 and Histogram H. 7). The distribution was 
highly skewed, with only a few onsets at older ages, and maximum number of 
subjects never reported his or her phobia as a problem for which he or she sought 
mental treatment, but only a few about 5.3% reported to have visited the hospital for 
BII phobia once or twice and these also does not continued the treatment for this 
phobia, and about 94.7% of the subjects with BII phobia had never told a physician or 
other health professionals of their phobic behaviour. 
The very interesting thing to note here is, that during our survey programme many of 
the subjects either did not want to share their phobia with us or they hide what and 
how they are living with their phobia, because of their fear with medical treatment, as 
they were fearing that we are giving them injections for its treatment or recommend 
other medical procedure like that. 
Inlieritance Pattern 
From family studies and pedigree analysis, it was also found that the pedigrees show 
a variation among the inheritance pattern. In some of the pedigrees it was found that 
the proband has directly inherited BII phobia from parents, as most of the pedigrees 
(Pedigree groups Al to A5, Bl to B5 and CI to C5) show continuous inheritance and 
expression from grandparent generation to parent generation and then to the children 
and these were recorded as "pedigrees of continuous inheritance and expression" and 
its percent mean value from the data has been found to be as 79.70% (SD±10.30). 
(Table T. 7 and Histogram H. 8). Almost 61% of the cases are such where the 
sufferer has one or more first degree relative affected from the same disorder. 
However a number of pedigrees were found to have a discontinuous expression of 
this disorder, where a proband or other relatives (sibs etc) were affected while their 
parents were normal, and their grandparents have lived or living presently as BII 
phobics and these were recorded as "pedigrees of discontinuous expression" 
(pedigree groups Dl to D5) and its percent mean value from the data has been fovmd 
to be as 13.85% (SD±9.39). 
A number of pedigrees (pedigree groups CI to C5) have shown BII phobia, only in 
two generations that is the generations of children's and parents and no any record of 
this phobia in grandparent generation (may be because the proband was unaware of 
their illness) or second and third generation that is the generation of parents and 
grandparents and not any individual have experienced BII phobia yet in the children 
perhaps due to the normal genes contributed by other parent or because the children 
has not attained the age of onset of BII phobia till now and may experience it in the 
later stages of life, their percent mean value from the data has been found to be as 
11.46% (SD±7.52). There were a number of pedigrees of the subjects who have got 
BII phobia all of a sudden and there have not been any record of BII from their parent 
or grandparent generation and these pedigrees have been recorded as "pedigrees 
showing spontaneous expression". Where spontaneous gene activation for this phobia 
may be the possible cause, their percent mean value was found to be as 6.42% (SD 
±1.46) (Pedigree groups El to E5). (Table T. 7 and Histogram H. 8 and H.9) 
Persistence of BH Phobia 
BII phobia prevalence is one of the important features to be studied in the population. 
As BII phobia prevalence varies from population to population, its persistence also 
varies from person to person we have recorded the subjects having three different 
types of persistency's (Table T. 9 and Histogram H. 9). First: those who have BII 
phobia persistence from one year to ten years. Second: those who have BII phobia 
persistence in between ten to twenty years and the third and last group: those who 
have persistence of BII phobia for more than twenty years. The percent mean value of 
subjects in the first group that is having persistence fi-om one year to ten years is 
found to be as 38.97% (SD±5.22) and the percent mean of subjects fi-om group 
second that is having persistence in between ten to twenty years is 33.31% (SD±4.87) 
and third and final group those having persistence for more than twenty years is 
having the percent mean value of 27.68% (SD±2.38) (Table T. 8 and Histogram 
H.10) 
The probands firom all the pedigree samples examined in this study were grouped into 
four age ranges and all of 167 probands of BII phobia from all samples were in the 
following pattern. 76% (127) of cases were in the age group between 5-25 years with 
a mean age of 14.84 SD±5.57, while only 14.97% (25) cases were in between the age 
group of 26-40 years with a mean age of 32.11 SD±4.18 and the probands within the 
age group between 41-55 years mean age of 48.80 SD±4.21, were only 11 cases that 
is about 6.586%, while only 4 cases that is about 2.395% above 56 years were 
observed whose mean age 63.00 SD±5.16 years. 
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Histogram (H. 1) Showing the gender wise differences in the percentage of sufferers 
for BII Phobia in five samples from diff. places. 
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DISCUSSION 
Blood injury and injection phobia deals with a persons personal fear of injury, 
injection / needles and blood will cause them to strongly avoid most medical 
proced\ires. This phobia is most commonly noticed after a person faints or experiences 
a change in heart beat rate/extremely uncomfortable sensations around the sight of 
blood. Most cases are discovered in early childhood and require some method of 
treatment to overcome. 
This phobia can have grave implications and may even become life threatening, when 
it prevents essential medical procedures such as urgent surgery, blood transfixsion, or 
insulin injections, where the treatment is almost always mandatory. Indeed such 
emergency is not an uncommon reason for referral (Mark 1987). Such patients avoid 
close contact with sick people, refiise hospital appointments and would not view 
television programme or read newspaper reports about trauma or disasters. Women 
sufferers (in severe cases) may even avoid pregnancy as child birth is associated with 
blood and medical procedures (Mark 1987). 
There is a great variation in the prevalence rates of BII phobia between males and 
females. It is evident from our studies that the percent prevalence rates of BII phobia 
in females is high 23.86 (±SD 8.18) which is slightly more than double the prevalence 
percentage of BII phobia in males 11.19 (±SD 5.35). The higher rate of female 
prevalence of this phobia is also evident from the earlier studies and is comparable to 
estimates obtained from prior studies reported in the literature for specific phobias as a 
general class, as is evident from the reports of Serrano Blanco et al., (2010) 6.6%, 
Becker et al., (2007) 9.9% (women only). Wells et al., 7.3%, Kessler et al, (2005) 
15.7% (women only), Fredriksson et al., (1996) 19.9% Kendler et al (1992) 20.5% 
(women only), Robins et al (1984) 8.5-25.9%, Agras et al. (1969) 7.7%. Costello 
reported a 12 month prevalence rate of specific phobia in woman varying between 
4.9% and 12.5% depending on the phobias included (Costello 1982 and finally 
Wittchen who used the DSM criteria and observed a 6 months prevalence of 4.1% and 
lifetime prevalence of 8%) with lower for specific phobia in men and woman (Wittchen 
1986). Specific phobias in general are twice as common in women as in men 
(Fredriksson et al., 1996, Choy et al., 2007). Blood and injection phobia is equally 
distributed in men and women in some studies and in others there is a female 
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histone demethylases JARIDIC and UTX, are coded by X-linked genes which are 
not X-inactivated in females. The higher expression of JARIDIC and UTX in 
females could contribute to sex differences in brain development and behavior. (Jun 
and Megan, 2011) 
Evidence that X-linked imprinted genes may influence brain and behavioral processes 
in humans has been obtained primarily from studies in Turner syndrome (TS), a 
developmental disorder often underpinned by monosomy for the X chromosome (45, 
X). In the first study of this type, Skuse et al. showed that the phenotype of subjects 
with TS differed according to whether their X chromosome was of maternal or 
paternal origin (Skuse et al., 1997). Briefly, TS females with a maternally inherited X 
chromosome (45, Xm) were foimd to be more impaired in social cognitive skills, 
verbal IQ and behavioral inhibition than TS females with a paternally inherited X (45, 
Xp). Moreover, the former group were apparently more vulnerable to developing 
autism (out of 80 X-monosomic subjects assessed, three met diagnostic criteria for 
autism, and all were 45, Xm). 
On the basis of their findings, the authors speculated that a paternally expressed X-
linked gene could confer protection against social cognitive deficits, a hypothesis 
which could explain the relative preponderance of males affected by autistic spectrum 
disorders (as in males such a gene will not be expressed). TS is characterized by a 
distinct cognitive profile including attention deficits. Hence, a recent study has used 
the TS experiment-of-nature to ascertain whether parental origin of the single X 
chromosome also influences vulnerability to ADHD (Russell et al., 2006); the authors 
found no evidence that this was the case, implying a certain degree of specificity to the 
actions of any X-linked imprinted genes affecting human brain fianction 
Our studies also show the significant differences in the relative frequencies of BIl 
phobia among the first, second and third degree relative. The frequency of this BII 
phobia among the 1st degree relative is 26.42 (±SD 8.59) and among the third degree 
relatives, while it was only 8.20 (±SD 8.56) among second degree relatives. Due to 
this increased number of BII phobics among the first and third degree relatives than 
second degree relatives, it is suggested that genetic components responsible for this 
phobia are lying in the recessive genes. The phobias are inherited from generation to 
generation through Non- Mendelian fashion. This also indicates that there are multiple 
or quantitative genes responsible for these phobic traits, which donot follow any 
sequential pattern for their transmittance down the generation. From the pedigrees it 
can be suggested that there is multifactorial inheritance which means many factors are 
involved in causing a phobia to individuals. These factors are usually both genetic and 
environmental, where a combination of genes from both parents, in addition to 
unknown environmental factors, produces the trait or condition. Multifactorial 
inheritance also supports our variation of BII phobia frequency among male and 
female, because often one gender is affected more frequently than the other in 
multifactorial traits. There appears to be different "threshold of expression" which 
means one gender is more likely to show the problem over the other. Familial 
aggregation is cormnon in multifactorial inheritance which is also evident from our 
pedigrees, where mostly multiple cases are present in the same family pedigree. This 
disorder occurs more frequently in one gender than in the other, but is not a sex linked 
trait. In addition to this first degree relatives of individuals belonging to the more 
rarely affected gender have a high risk of bearing the disease. In essence, Quantitative 
Genetics is an extension of simple Mendelian inheritance to phenotypes that do not 
exhibit classic recessive or dominant characteristics attributable to a single gene locus 
(Lander & Schork, 2006), but where numerous environmental and genetic influences 
are thought jointly to contribute to individual differences. Such traits are often referred 
to as complex or multifactorial (Hartl & Jones, 2002). 
Comorbidity 
Comorbidity in psychiatry is a rule rather than exception and generally a sufferer of 
one psychiatric illness often is suffered from other psychiatric illnesses. These 
psychiatric disorders are highly interconnected with each other, and they also overlap 
in their etiologies which increases the chances of being in comorbid with other 
illnesses or medical conditions. From our studies, high rates of comorbidity is 
conspicuous, and it is evident from the results that comorbidity of BII is high for 
depression which is 20.29 (±SD 3.77), followed by Agoraphobia, Animal Phobia, 
Panic disorder. Social phobia and OCD. Thus it is intended here that BII phobics are 
highly vulnerable of getting depression and other disorders stated above or has an 
increased chance of being depressive. Agoraphobic or Animal Phobic than non BII 
phobic persons. It is widely acknowledged that with mental disorders, concurrent 
comorbidity is the norm rather than the exception, with the rate dramatically 
increasing if hfetime comorbidity is assessed (Widiger & Samuel, 2005, Park et al. 
2013). The excessive levels of comorbidity between mental disorders are perhaps most 
convincingly demonstrated in the earher studies (Kessler et al., 1994, 2005). 
The total genetic constitution of an organism is referred to as the genotype, while the 
organism's observable characteristics are referred to as the phenotype. All humans 
have the same set of genes, but individual genes exist in alternative forms, referred to 
as alleles. When we say that a trait is heritable, we are implying that at least one allele 
has a measurable effect on the trait (Plomin, DeFries, McCleam, & McGuffm, 2001). 
Different genes exist in a different number of versions in the population, and different 
traits are influenced by various numbers of genes. Disorders caused by mutation in a 
single allele, are referred to as "single gene disorders", or monogenic. Phenotypes such 
as mental disorders are believed to be influenced by a number of genes, and hence 
referred to d& polygenic and complex. 
Comorbidity is high within clusters of related disorders, such as the anxiety disorders. 
Curtis (1998) found that nearly 76% of individuals with a lifetime DSM-Ill-R simple 
phobia reported one or more other co-occurring phobias. 
Epidemiological research has firmly established that the observed comorbidity is not 
merely an artefact of overlapping classification criteria or recruitment bias, but is 
instead a result of many factors (Klein & Riso, 1993). Twin samples have also showed 
high levels of comorbidity i» a study by Neale & Kendler, 1995. And they propounded 
that, the occurrence of one disorder can increase the risk for another disorder, or two 
disorders can represent alternate forms or manifestations of the same underlying 
liability. The few studies to investigate these questions by means of quantitative 
genetic methods offer tentative results to the effect that many risk factors for 
psychopathology are not disorder-specific, and that a large number of psychiatric 
disorders may be explained more parsimoniously by a small number of underlying 
factors (Kendler et al., 1995a). The tentative conclusion that can be drawn ft-om the 
existing body of evidence, lends most credence to correlated genetic and 
environmental liabilities as an explanation of the comorbidity in psychopathology 
(Krueger & Markon, 2006; Middeldorp, Cath, Van Dyck, & Boomsma, 2005). 
Age of Onset. 
The age of onset of this phobia from this study shows a sHght variation among the 
samples and in between males and females. The mean age of onset among the males 
was found to be as 9.3 years (±SD 3.27) and in females this onset was little earher 7.5 
years (±SD2.51). Blood and injection phobia usually starts in childhood or 
adolescence and it is uncommon for adults to acquire this phobia. Other workers have 
reported almost the same age range for example, in a study by Becker almost 100% of 
the individuals with blood and injection phobia had acquired phobia before age 18 
(Becker et al., 2007) another study by Ost shows that 60.5% of the blood phobics and 
69.5% of the injection phobics experienced the onset of blood and injection phobia 
before age 10 (Ost 1992a). The mean age were 8.6 years (SD-3.9) for blood phobic's 
and 8.1 years (SD=4.9) for injection phobics. The mean age of onset was 10.5 years in 
a study by Bienvenu who interviewed 1920 individuals using the DSM criteria for 
blood and injection phobia (Bienvenu and Eaton 1998). However, the distribution in 
this study was highly skewed with only a few onsets at older ages, the median age of 
onset was 5.5 years other authors have described a median of 7-12 years for onset of 
this phobia (Thyer et al., 1985; Himle et al., 1989, Neale et al., 1994, Lipsitz et al., 
2002). The onset of this phobia in this age range indicates that the persons which are 
genetically predisposed for BII phobia generally having its onset to its fullest in 
childhood and adolescence. 
Pedigrees of Continuous, Dis-continuous and Spontaneous expression. 
From the pedigree analysis and from results of this study, it is evident that most of the 
pedigrees almost 79% are those of continuous expression type that is the BII phobia is 
expressed continuously from generation to generation, followed by a less number of 
pedigrees of discontinuous expression. From the pedigrees of continuous inheritance it 
is obvious that the BII phobic case are having one or more relatives (mostly first 
degree relatives) suffered from the same disorder, which is also clear from the earlier 
literature (Ost et al 1997, Kendler et al. 1995, and the recent one by Houtem et al. 
2013) where more than 70 percent of BII phobics cases have one or more first degree 
relatives suffered from the same disorder. This is again the case of multifactorial 
inheritance discussed earlier, however a number of pedigrees shows discontinuous 
inheritance which may probably be the case that the multifactorial inherent genes of 
BII phobia doesn't get that environment whi^i^^j^^jft'-di^pos^s them to this phobia 
and creates a generation gap. There are also some cases of spontaneous expression of 
this phobia from pedigrees, where the BII phobic cases had got this phobia all of 
sudden with not any history of such phobia among the relatives. This may be the case 
of sudden mutation of the genes due to various environmental risk factors which 
render the person phobic all of a sudden. High number of continuous inheritance 
pedigrees in our studies also indicates that this phobia is strongly familial and genetic 
components are fully responsible for the occurrence of this phobia. The genetic 
components responsible for this phobia and others have been reported in the literature. 
A chromosome 14 locus reported to be significantly linked to simple phobia. 
Chromosome 14 locus is most likely to play a role in susceptibility to a range of 
anxiety-related phenotypes (Gelemter et al 2003). 
These observations are consistent with a hypothesis suggested by patterns of 
comorbidity among the anxiety disorders and presented by Gelemter et al. (2001) and 
earlier by Kendler et al. (1995) in a broader context, that there may be risk loci that 
increase risk for several anxiety disorders and other risk loci that are more specific to 
certain anxiety disorders. Without the existence of such shared risk loci, it is difficult 
to explain the elevated rates of co-segregating social and simple phobia in pedigrees 
recruited not for these disorders but for high rates of panic disorder. A duplication of 
part of chromosome 15q, apparently inherited in a non Mendelian fashion, has also 
been found to be strong associated with phobic disorders. This usual genetic 
mechanism may partly explain the heritability of phobia and other complex traits 
(Flint, 2003). Gratacos (2001) identified an interstitial duplication of human 
chromosome 15q24-16q26 (named DUP 25), which is significantly associated with 
panic disorder in non familial cases. Mosaicism (different forms of DUP 25 within the 
same family), and absence of segregation of 15q24-26 markers with DUP 25 and the 
psychiatric phenotypes suggest non Medelian mechanisms of disease causing mutation 
(Gratocosetal., 2001). 
The polymorphic region 5HTTLPR of the SLC6A4 gene was examined in relation to 
phobic anxiety and cognitive function. The study in which sixty four community 
dwelling adults were genotyped for the 5HTTLPR polymorphism to examine whether 
late life phobia are associated with the short(s) allele and whether cognitive 
impairment may precipitate phobic behaviors in association with the s-allele (Schultz 
et al, 2005). 
The norepinephrine transport;er plays the physiological role of reuptake of 
norepinephrine and dopamine into presynaptic neurons, terminating 
neurotransmission. It is a target for some medications that are effective for the 
treatment of social anxiety disorder, including venlafaxine (Gorman and Kent 2002) 
and, possibly, paroxetine (Owens et al. 2000). Adrenergic tone clearly plays a role in 
the experience of some of the physiological concomitants of anxiety, and blockade of 
norepinephrine can be involved in relief of some symptoms of anxiety. Furthermore, 
there is preliminary evidence that dopamine metabolism may be abnormal in social 
phobia (Tiihonen et al. 1995). These observations make SLC6A2 (which succeeded 
"SLC6A5" as the locus symbol for this gene) a clear candidate gene for anxiety 
disorders in general (Gelemter et al 1993) and social phobia in particular. 
Persistence of BII Phobia. 
Long Persistence of blood phobia is also one of the characteristics to this phobia. Once 
attained by the person gets sticked to him for the pretty long time. Blood phobia is 
controlled by multiple genes laying its impact for the long time. As being genetically 
controlled trait, it is very difficult to treat or control it fully, by using medications, 
therapies etc and It creates a long lasting imprint on the brain and this may be one of 
the possible reasons for such long lasting persistence of this phobia. From our studies 
this long lasting persistent feature of BII phobia is also evident and we have 
documented BII phobics in three classes based on their persistence that is one to ten 
years, ten to twenty years and the third and final class as those having this phobia 
persistent for above twenty years. This shows that there is also lasting impression of 
this phobia in our studied samples. 
Fainting 
Fainting is one of the specific character of blood injury and injection phobia, it is 
evident fi^om the results that percent mean value of fainting probands is 55.77 
(SD±4.31) fi-om all cases in which percent mean value of female fainting probands 
were 74.41(SD ±4.46) and the percent mean value of male fainting probands were 
25.57% (SD ±4.46) these results also coincides with the results of earlier studies (Ost 
et al, 1984, Thyer et al., 1985, Ost 1992a, Olatunji et al., 2006) whose studies shows 
about 70-80% of the persons with blood and injection phobia faint when exposed to 
the phobic stimuli. 
It is not surprising that the earhest adaptationist hypothesis of BII phobia in the 
neurobiological literature was that blood-induced fainting increases the probability of 
survival because a radical drop in blood pressure minimizes blood loss or 
cardiovascular shock, serving an adaptive function in the case of injury (Graham 1961, 
Engel 1968). As Page pointed out, however this hypothesis does not explain fainting 
provoked by an injection or by trivial skin injuries, neither of which involve blood 
loss. Furthermore, cardiovascular research has consistently found that vasoconstriction 
and tachycardia are the initial responses to blood loss, whereas faintness or fainting is 
not experienced until there is a 30% drop in blood volume (Bemtson et al 1994, 
Appenzeller, 1997). 
Gene-Environment Interaction in Human Disease 
We know that genes alone do not cause many common diseases like heart disease, 
diabetes, cancer and depression, as well as alcohol, tobacco and other drug addictions. 
Rather, many genes influence our risk of developing diseases, and whether or not that 
risk actually leads to disease depends on a lifetime of complex interactions between 
our genes and our environments. Similarly, certain environments that are known to 
increase our chances of physical or mental health problems are especially risky for 
people who also have a particularly vulnerable genetic make-up. 
Almost all diseases result from a complex interaction between an individual's genetic 
make-up and environmental agents. Subtle differences in genetic factors cause people 
to respond differently to the same environmental exposure. This explains why some 
individuals have a fairly low risk of developing a disease as a result of an 
environmental exposure, while others are much more vulnerable. As scientists learn 
more about how genetics and environmental factors work together to cause human 
diseases, they will be able to develop new strategies for the prevention and treatment 
of many illnesses. 
Since the days of Archibald Garrod, it has been increasingly accepted that the 
aetiology of most common diseases involves not only discrete genetic and 
environmental causes, but also interactions between the two. In the context of medical 
genetics and epidemiology, the study of gene-environment interactions is useful for 
several reasons. If we estimate only the separate contributions of genes and 
environment to a disease, and ignore their interactions, we will incorrectly estimate the 
proportion of the disease that is explained by genes, the environment, and their joint 
effect. The identification of susceptibility and/or resistance alleles in candidate-gene 
studies provides direct evidence that these genes and their biological pathways are 
relevant to specific diseases in humans. Understanding gene-environment interactions 
might allow us to give individualized preventive advice before disease diagnosis, in 
addition to offering personalized treatment after a disease, or disease susceptibility, 
has been diagnosed. Some gene-environment interactions can be identified without 
any molecular analysis; one example is the much stronger effect of sunlight exposure 
on skin cancer risk in fair-skinned humans than in individuals with darker skin (Green 
and trichopoulos 2002). Others can be observed as a reproducible effect of an 
environmental exposure on a susceptible individual; for example, the flushing 
response seen after alcohol ingestion in individuals with low-activity polymorphisms 
in the aldehyde dehydrogenase gene (Takeshita et al. (1996). However, our rapidly 
expanding ability, particularly after the completion of the Human Genome Project, to 
define genetic differences at the DNA-sequence level is opening up a vast new terrain 
in the search for gene-environment interactions. 
The genes are in a constant threat of mutating fi-om one state to other like some sets 
"on" by one process and other goes "off by other process. Because of this nature of 
on and off to the genes we presume that the environmental risk factors interacts with 
the genetic components and helps in either the expression of certain dormant genes or 
suppression of certain active genes. The confirmation of heritable components to 
phobias including BII phobia fi^om the previous studies and fi-om our own indicating 
that the genes responsible for phobia are heavily loaded in the human genome. Fear is 
a natural entity, which has evolutionary significance. It may be hypothesized that 
normal fear genes may turn into phobic ones due to certain environmental risk factors. 
One scan of epigenetic markers in the brain identified about 60 genes that are different 
between psychiatric patients and healthy people. Many of these genes code for 
proteins that are important for signalling between brain cells (Tsankova et al., 2007). 
Some drugs that are used to treat mental illness work by changing gene expression. 
These changes in gene expression are stabilized through epigenetic mechanisms (DNA 
methylation and histone modification), reversing the effects of the disease (Sweatt 
2009). 
When Waddington created the term epigenetics, Httle was known about the expression 
of genes. Waddington and others eventually realized that development involved 
networks of interactions between genes. By the 1990s, Hall wrote that epigenetics 
involves genetic and non-genetic factors that affect gene expression. Hall further noted 
that the code of heredity includes an extra layer in addition to DNA (Jablonka 2002). 
Epigenetic changes do not alter or mutate the DNA; instead epigenetic mechanisms 
affect DNA by regulating the expression of genes (Urdang 2009). Therefore, due to 
their regulatory fimction, epigenetic mechanisms are still considered to 
occur upon or above the DNA, (Bagot 2010) without actually altering it. (Wong et al., 
2011) 
The mechanisms involved in the epigenetic modification include DNA methylation 
(Mehler 2008) and histone modification (Maze 2011). DNA methylation, the best 
understood epigenetic modification, (Campbell et al. 2011) results in the inability of 
genetic information to be read from DNA (Reik 2007). In other words, epigenetic 
modification can turn off a gene (Gottesman 2005) and this mechanism of turning off 
genes is reversible (Campbell et al., 2011 and Gottesman 2005) and can revert to its 
original form. 
Epigenetic modifications can also be inherited from one generation to the next (Goto 
and Monk 1998). Specifically, the effects of epigenetics may be transmitted from 
parents to children through meiosis (Campbell et al. 2011 and Rakyan 2002) and 
mitosis(Campbell et al. 2011 and Lim et al. 2010) - processes that pass genetic 
information from the father into the sperm and from the mother into the egg (Guyton 
2000) Hence, subsequent generations may be affected by the epigenetic changes that 
took place in the parents (Goto and Monk 1998). 
Mental illnesses have affected children's of the worlds intelligent peoples like Albert 
Einstein, Sir Isaac Newton and Ernest Hemingway like peoples and is continuously 
affecting the peoples of every comer from length and breadth of the world rendering 
the intelligent population from active to passive, makes the normal being an abnormal 
one, the self-confident one confident less and vacillated, turns optimistic one's 
pessimistic. Mental disorders have changed the economies of most of the developed 
and developing countries from good to bad, and billions of dollars are put to treat these 
mental disorders in united states alone and the condition is almost same in every 
covmtry of the world, where part of the country's economy gets washed away, because 
of these mental disorders, as it makes the worlds intelligent peoples handicapped. 
There is a need to confrol or curb the occurrence of these mental disorders and to help 
the nations to survive its disastrous loss. However if this mental illness is confroUed up 
to half the number which is actually present, the world would save from it billions and 
billions of dollars which can be used in purposes of prosperity for nations. 
Behaviors are quantitative traits and their genetic underpinnings are complex. 
Phenotypic variation between individuals is attributable to the segregation of genetic 
polymorphisms at many interacting loci, with effects that are sensitive to the 
environment. Understanding the genetic and environmental influences on the 
manifestation of behavior is important from the dual perspectives of human health and 
evolutionary biology. Psychiatric disorders exert a heavy burden on health care in 
modem societies. Development of effective freatments depends on understanding the 
genetic mechanisms and environmental triggers that predispose to these disorders. 
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CONCLUSION 
> Behaviors are quantitative traits and their genetic underpinnings are complex. 
Phenotypic variation between individuals is attributable to the segregation of genetic 
polymorphisms at many interacting loci, with effects that are sensitive to the 
environment. Understanding the genetic and environmental influences on the 
manifestation of behavior is important from the dual perspectives of human health 
and evolutionary biology. 
> From the behavioural studies and studies on brain and behavioural change due to 
various neuropsychiatric disorders, the nature of the brain is found to be plastic and 
changing. It is also believed that a wide variety of experiences and agents can alter 
synaptic organization and behavior and we strongly support this theory. 
> In sum, the structure of the brain is constantly changing in response to an 
unexpectedly wide range of gene-environment interactions. Understanding how the 
brain changes and the rules governing these changes is important not only for 
imderstanding both normal and abnormal behavior, but also for designing treatments 
for behavioral and neurobiological disorders. 
> Family and pedigree studies exhibit that phobic anxiety are influenced by genetic 
factors. However these genetic factors are not following the simple Mendelian trend 
of inheritance, because there are pedigrees of continuous, non continuous and also 
spontaneous expression which suggest that the loci involved are QTLs and are 
sensitive to many environmental factors and epigenetic mechanisms for their 
expression. 
> About 70 percent of Blood and injection phobics have a first-degree relative (parent, 
child or sibling) with this specific phobia. This serves as evidence that BII phobia has 
a genetic component. 
> In conclusion the data indicate that fear of blood, injury and injections are 
substantially caused by genetic factors and less likely by environmental factors that 
are unique to the individual. 
> Blood phobia is a trait which is found to be more prevalent in females as compared to 
males. Neurobiologically one may hypothesize that at the transcriptome level; BII 
phobia involves a developmentally sensitive gene expression mechanism that, in 
females become more intense under the influence of their hormones. Therefore it is 
categorised as sex influenced trait. 
> Comorbidity in psychiatry is rule rather than exception and BII phobia is following 
that same rule and is also found to be highly comorbid. Usually a person with this 
type of specific phobia have other psychiatric problems cormected to it like panic 
disorder, depression, agoraphobia, animal Phobia social phobia, OCD, etc. 
> Blood phobia proves much dreadful problem at times, when it coincides with other 
medical problems like cancer, diabetes or other health related issues which needs an 
important life saving surgeries. As individuals with BII phobia donot consent for 
injections, medications and other life saving surgeries and it makes it the matter of 
life and death to a BII phobic who avoids these types of treatments. 
> While none of the blood phobic patients in our study had sought mental health 
treatment specifically for phobia, which is also found by Bienvenu and Eaton (1994) 
in Baltimore ECA study. Therefore it is necessary for the physicians to routinely 
query about BII phobia. 
> This phobia is unique in that almost more than 50% of the sufferers faint in the 
presence of their phobic object. The data found that such fainting is highly familial 
and may cause by genetic factors. Future research can continue to identify the unique 
environmental variables that cause blood fear, and can also focus on the mechanism, 
whereby the genes associated with fainting can give to blood fears. 
> Psychiatric disorders are at the helm to heavy burden on health care in modem 
societies. Development of effective treatments needs to understand the genetic 
mechanisms and environmental triggers that predispose to these disorders. 
> From the evolutionary perspective, behaviors are components of fitness because they 
mediate survival through adapting various new mechanisms which then are inherited 
from generation to generation. Thus, there is a need to research on these and get an 
insight to understand the genetic basis of variation in behaviours which can inform 
our understanding of adaptive evolution, and also help us to prepare targeted 
therapeutic drugs, which will save us from the huge loss due to these neurobehavioral 
disorders. 
> There is a need for the identification of specific susceptibility genes that would signal 
a major advance in our understanding of the pathophysiology of phobic anxiety at a 
molecular level. Practical consequences of cloning such genes would include the 
ability to develop methods of early detection of individuals at risk, targeted 
prevention strategies and more specific and effective pharmacotherapeutics. 
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SUMMARY 
Behaviors refer to the actions made by organisms, in conjunction with their 
environment, which includes the other systems of organisms around as well as the 
physical environment. It is the response of the organism to various stimuli or inputs, 
whether internal or external, conscious or subconscious, overt or covert and voluntary 
or involuntary. 
Blood injection and injury (BII) phobia is a specific phobia according to DSM-IV-TR 
and deals with fear of blood, injury, injection / needles and will cause them to 
strongly avoid medical procedures. This phobia is most commonly noticed after a 
person faints or experiences a change in heart rate and extremely uncomfortable 
sensations at the sight of blood. The diagnostic criteria for blood and injection phobia 
according to the DSM-IV are given 
Marked and persistent fear that is excessive or unreasonable cued by the presence or 
anticipated presence of a blood, injvired person, or bleeding wound etc. 
Exposure to the phobic stimulus almost always provokes an immediate anxiety 
response, which may take the form of a situational bound or situational predisposed 
panic attack. 
The person recognizes that the fear is excessive or unreasonable. 
The phobic situation is avoided or else endured with intense anxiety or distress. 
The avoidance, anxious anticipation, or distress in the feared situation interferes 
significantly with the persons normal routine, occupational (academic) fiinctioning, 
social activities or relationship and there is marked distress about having the phobia. 
In individuals under age 18 years, the duration is at least 6 months. 
It has been found that almost 70% of the BII phobia has one or more ist degree 
relatives suffered from the same disorder. A sfrong genetic component is considered 
to be responsible for this phobia, because of its strong familial history. 
This phobia is distinct from all other phobias in developing bradycardia and fainting, 
when in contact with blood injury stimuli. This is diphasic where initially there may 
be a slight rise in heart rate and blood pressure followed by marked vasovagal 
slowing of heart rate and then fainting. So far as literature on BII phobia is concerned 
there is not any record (s) of work conducted on the specific phobia in this 
subcontinent, so there was a need to work on this phobia and to get a general 
overview of this dreaded neurobehavioral disorder, which can be used to formulate 
the health related policies and prevent blood phobics from this and other health 
related complications which are directly or indirectly related with BII Phobia. 
METHODOLOGY 
Due to limitations of the techniques like breeding, transgenic and gene knockout 
which are common for studying animal behaviour, the common research 
methodologies like population studies, family studies, pedigree analysis etc are used 
to study human behaviour. The present study was conducted by surveying five 
different localities of Aligarh using methodologies like population studies with a 
selected semi structured questionnaire according to DSM-IV-TR having Chronbachs 
a value equal to 0.972, Pedigree Analysis, and interview based survey. 
OBSERVATION AND RESULTS 
Five random samples from different places of Aligarh were collected and a total of 
167 pedigrees were constructed from these samples of 3261 individuals. Out of these 
1648 were males and 1613 were females subjects. The sufferer males were found to 
be as 196 (11.91%, SD±5.35) and sufferer females were 384 (23.36%, SD±8.18), 
showing a higher prevalence rate of this phobia in females as compared to males, 
almost slight more than a double. However an overall (male and female) mean 
percentage of sufferers are approximately 17.18%, (SD±4.17). Frequency of this 
phobia among the 1st, Ilnd and Ilird degree relative of probands was compared and 
their percent mean values were found to be as 26.42 (SD±8.59), 8.20 (SD±8.56) and 
20.91 (SD±7.74). Fainting as a specific character to this phobia, as discussed earlier 
was analysed in sufferer males and females. Females were found to be having higher 
fainting rate than males and their percent mean value were 39.40 (SD±8.94) in males 
and 64.09 (SD±6.49) in females. 
Comorbidity in psychiatry is a rule rather than exception and BII phobia is also found 
to be highly comorbid with number of secondary disorders. In this study BII phobia is 
found to be in comorbidity with certain disorders whose percent comorbidity mean 
were found to be as follows:-
Depression 20.29 (SD±3.77), Agoraphobia 15.71(SD±5.40), Animal phobia 13.17 
(SD±2.76), Panic disorder 6.13 (SD±2.15), Social phobia 5.17 (SD±1.28), Obsessive 
Compulsion Disorder (OCD) 2.57 (SD±2.49). 
The mean age of onset from all the samples were found to be as 9.3 (SD±3.27) years 
in males which was higher as against females 7.5 (SD±2.51) years. 
Data were also analysed to check the continuous, Non continuous and Spontaneous 
expression of BII phobia among the families under observations, it was found that 
79.70% (SD±10.30) pedigrees show continuous expression of this phobia while 13.85 
(SD±9.39) as non continuous and only 6.42% (SD±1.46) pedigrees were showing 
spontaneous expression. The continuous expression in most of the pedigrees is 
showing that the genetic factors predominantly involve in the inheritance of BII 
phobia as compared to environmental factors which are mainly governing the 
differential gene expression in the sufferers and relatives. 
Persistence periods of this phobia were studied and were calculated in three age 
groups of persistence periods. Out of the total sufferers and 38.97% (SD±5.22) BII 
phobics were having persistence of one to ten years, 33.31% (SD±4.87) were found in 
persistence often to twenty years and 27.68% (SD±2.38) were having the persistence 
of more than twenty years. 
This study shows a bias towards the prevalence rates, age of onset and symptoms like 
fainting in males and females. Females have higher prevalence rates of this phobia 
than males. This condition proves nature of BII phobia, because in the presence of 
female sex hormones (estrogens), that is the causative genes show more intense 
expression as compared to the male hormones. For example in metafemales with 44 + 
XXX and 44 + XXXX conditions, degree of mental retardation increases with every 
dose of extra X chromosome. Besides in the brain there are differences in the 
expression of X and Y linked genes. The X chromosome plays an important role in 
brain development and function, as evidenced by disproportionately high content of 
genes whose mutations cause mental retardation. 
Imprinted genes are mono allelically expressed in a parent of origin dependent 
maimer and can affect brain and behaviour phenotypes. The X-chromosome is 
enriched for genes affecting neurodevelopment and is donated asymmetrically for 
male and female progeny; hence X- linked imprinted genes could potentially 
influence sexually dimorphic neurobiology. This study also shows a non Mendelian 
inheritance from pedigree analysis, which indicated there are multiple loci or 
quantative trait loci (QTLs) responsible for these phobic traits. Multifactorial 
inheritance is suggested for this phobia, where many factors are involved to cause a 
specific trait, whose one main characteristic is variation in expression of trait among 
males and females. Family aggregation is common in multifactorial inheritance which 
is also evident from our pedigrees, where mostly multiple cases are present in the 
same family pedigree. 
Comorbidity of this phobia is also evidenced from literature and usually a sufferer of 
one psychiatric disorder is vulnerable to secondary disorders as well. It is widely 
acknowledged that with mental disorders, concurrent comorbidity is the norm rather 
than exception. 
Higher percentage of continuous expression of this phobia also indicates that this 
phobia is sfrongly familial and genetic components are responsible for this phobia is 
being reported in the literature. Chromosome 14 locus is most likely to play a role in 
susceptibility to a range of anxiety related phenotypes (Gelemter et al. 2003). 
Gratacos (2001) identified an interstitial duplication of human chromosome 15q24-
16q26 (named DUP 25) which is significantly associated with panic disorder in non 
familial cases. Polymorphic region 5HTTLPR of the SLC6A4 gene was examined in 
relation to phobic anxiety and cognitive function. 
Behaviors are quantitative traits and their genetic underpinnings are complex. 
Phenotypic variation between individuals is attributable to the segregation of genetic 
polymorphisms at many interacting loci, with effects that are sensitive to the 
environment. Understanding the genetic and environmental influences on the 
manifestation of behavior is important from the dual perspectives of human health 
and evolutionary biology. 
The blood phobic individuals in the population doesn't consult the physician or attend 
a clinic and does not often use medication for this dreaded BIT phobia. This is most 
dreaded problem in them, because BII phobia often prevents the sufferer to attend 
hospitals or clinics where blood and blood related cues like injection, injury are 
common and this prevents them to use the twenty first century modem medication for 
a number of health related issues. 
Comorbidity in psychiatry is rule rather than exception and BII phobia is following 
that same rule and is also found to be highly comorbid. 
Psychiatric disorders are at the helm to heavy burden on health care in modem 
societies. Development of effective treatments needs to understand the genetic 
mechanisms and environmental triggers that predispose to these disorders. 
There is a need for the identification of specific susceptibility genes that would signal 
a major advance in our understanding of the pathophysiology of phobic anxiety at a 
molecular level. Practical consequences of cloning such genes would include the 
ability to develop methods of early detection of individuals at risk, targeted 
prevention strategies and more specific and effective pharmacotherapeutics. 
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